NO146985B - ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE PROLIN-AZETIDINE AND PIPERIDINE DERIVATIVES - Google Patents

ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE PROLIN-AZETIDINE AND PIPERIDINE DERIVATIVES Download PDF

Info

Publication number
NO146985B
NO146985B NO770464A NO770464A NO146985B NO 146985 B NO146985 B NO 146985B NO 770464 A NO770464 A NO 770464A NO 770464 A NO770464 A NO 770464A NO 146985 B NO146985 B NO 146985B
Authority
NO
Norway
Prior art keywords
proline
acid
methylpropanoyl
mercapto
formula
Prior art date
Application number
NO770464A
Other languages
Norwegian (no)
Other versions
NO146985C (en
NO770464L (en
Inventor
Miguel Angel Ondetti
David W Cushman
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/657,792 external-priority patent/US4046889A/en
Priority claimed from US05/751,851 external-priority patent/US4105776A/en
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of NO770464L publication Critical patent/NO770464L/en
Publication of NO146985B publication Critical patent/NO146985B/en
Publication of NO146985C publication Critical patent/NO146985C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00Thiols, sulfides, hydropolysulfides or polysulfides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/15Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
    • C07C53/19Acids containing three or more carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Description

Foreliggende oppfinnelse gjelder fremgangsmåte for fremstilling av nye prolinderivater og beslektede forbindelser med den generelle formel (I) The present invention relates to a process for the production of new proline derivatives and related compounds with the general formula (I)

hvor where

R er hydroksy eller C^-C^ alkoksy, R is hydroxy or C₁-C₁ alkoxy,

og R4 begge er hydrogen, C^-C^ alkyl, fenyl eller fenyl- and R 4 are both hydrogen, C 1 -C 4 alkyl, phenyl or phenyl-

C1-C7 alkyl, C1-C7 alkyl,

R2 er hydrogen, C^- C^ alkanoyl eller benzoyl, R 2 is hydrogen, C 1 -C 4 alkanoyl or benzoyl,

R^ er hydrogen, hydroksy eller C^- C^ alkyl, R^ is hydrogen, hydroxy or C^-C^ alkyl,

m er 1 til 3, og m is 1 to 3, and

n er 0 til 2. n is 0 to 2.

Stjernene angir asymmetriske karbonatomer. Hvert av karbonatomene som bærer en substituent R^, R^ og R^ er asymmetrisk når denne substituent er forskjellig fra hydrogen. The asterisks indicate asymmetric carbon atoms. Each of the carbon atoms bearing a substituent R 1 , R 2 and R 3 is asymmetric when this substituent is different from hydrogen.

C1~C7 alkylgruppene som er representert ved hvilke som The C1~C7 alkyl groups represented by which

helst av de variable omfatter lineære og forgrenede hydrokarbon-radikaler fra metyl til heptyl, f.eks. metyl, etyl, propyl, preferably of the variables include linear and branched hydrocarbon radicals from methyl to heptyl, e.g. methyl, ethyl, propyl,

isopropyl, butyl, isobutyl, t-butyl, pentyl, isopentyl og lignende. isopropyl, butyl, isobutyl, t-butyl, pentyl, isopentyl and the like.

C^-Cy alkoksygruppene er av samme slag bundet til oksygen, The C^-Cy alkoxy groups are of the same type bound to oxygen,

f.eks. metoksy, etoksy, propoksy, isopropoksy, butoksy, isobutoksy, t-butoksy og lignende. e.g. methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, t-butoxy and the like.

C^-C^ alkanoylgruppene er de som har acylradikaler av de The C^-C^ alkanoyl groups are those that have acyl radicals of them

lavere ( C2~ C^)-fettsyrene, f.eks. acetyl, propionyl, butyryl, lower (C2~ C^) fatty acids, e.g. acetyl, propionyl, butyryl,

isobutyryl og lignende. isobutyryl and the like.

Produktene med formel I og de foretrukne undergruppene The products of formula I and the preferred subgroups

kan fremstilles ifølge forskjellige syntesemetoder. can be produced according to different synthesis methods.

Generelt fremstilles de nye produktene ved å acylere en forbindelse med formel (III): In general, the new products are prepared by acylating a compound of formula (III):

med en syre med formel (IV): with an acid of formula (IV):

eller dens kjemiske ekvivalent. or its chemical equivalent.

Sluttproduktet kan således fremstilles ikke bare ved direkte acylering med en syre med formel IV, men også ved hjelp av mellomprodukter som f.eks. The end product can thus be prepared not only by direct acylation with an acid of formula IV, but also by means of intermediate products such as e.g.

a) a)-halogenalkansyrer med formel (V) : a) a)-haloalkanoic acids of formula (V):

hvor X er brom, klor eller jod, eller where X is bromine, chlorine or iodine, or

b) en tosyloksyalkansyre, dvs. at X i formel V er tosyloksy b) a tosyloxyalkanoic acid, i.e. that X in formula V is tosyloxy

c) en substituert akrylsyre med formel (VI): Produktet av denne acylering underkastes så forflytning eller addisjon med anionet av en tiol eller tiosyren med formel (VII): c) a substituted acrylic acid of formula (VI): The product of this acylation is then subjected to displacement or addition with the anion of a thiol or the thioacid of formula (VII):

Acylering kan også gjennomføres ved hjelp av et tiolakton med formel (VIII): Acylation can also be carried out using a thiolactone of formula (VIII):

for å danne et produkt hvor F^ er hydrogen. to form a product where F^ is hydrogen.

Fra en forbindelse med formel (II): hvor Y er en svovelbeskyttende gruppe som f.eks. C^-C-y alkanoyl, fenyl-(C1~C7)-alkanoyl, benzoyl, benzyl, trifenylmetyl, eller en annen svovel-beskyttelsesgruppe, fjernes Y for å danne en forbindelse hvor R ? er hydrogen. "Avbeskyttelse" kan gjennom-føres på vanlig måte som f.eks. ved behandling med varm trifluoreddiksyre, kold trifluormetansulfonsyre, kvikksølv(II)acetat, natrium i flytende ammoniakk, sink og saltsyre eller lignende. For omtale av disse metoder vises til Methoden der Organischen Chemie (Houben-Weyl), vol. XV, del I, side 736 og følgende (1974). From a compound of formula (II): where Y is a sulfur protecting group such as e.g. C^-C-y alkanoyl, phenyl-(C1~C7)-alkanoyl, benzoyl, benzyl, triphenylmethyl, or another sulfur protecting group, Y is removed to form a compound where R ? is hydrogen. "Deprotection" can be carried out in the usual way, such as e.g. by treatment with hot trifluoroacetic acid, cold trifluoromethanesulfonic acid, mercury(II) acetate, sodium in liquid ammonia, zinc and hydrochloric acid or the like. For discussion of these methods refer to Methoden der Organischen Chemie (Houben-Weyl), vol. XV, Part I, pp. 736 et seq. (1974).

Når syren med formel IV brukes som acyleringsmiddel, kan acyleringen utføres i nærvær av et koblingsmiddel som dicykloheksylkarbodiimid eller lignende, eller syren kan aktiveres ved dannelse av dens blandede anhydrid, symmetriske anhydrid, syreklorid, syreester eller bruk av Woodward-reagens K, N-etoksy-karbonyl-2-etoksy-l,2-dihydrokinolin eller lignende. En oversikt over acyleringsmetoder vises i Methoden der Organischen Chemie (Houben-Weyl), vol. XV, del II, side 1 og følgende (1974). When the acid of formula IV is used as the acylating agent, the acylation may be carried out in the presence of a coupling agent such as dicyclohexylcarbodiimide or the like, or the acid may be activated by formation of its mixed anhydride, symmetric anhydride, acid chloride, acid ester, or using Woodward's K,N-ethoxy -carbonyl-2-ethoxy-1,2-dihydroquinoline or the like. An overview of acylation methods appears in Methoden der Organischen Chemie (Houben-Weyl), vol. XV, Part II, pp. 1 et seq. (1974).

Forbindelser med formel III omfatter eksempelvis prolin, hydroksyprolin, 4-metylprolin, pipekolinsyre, 5-hydroksypipekolin-syre, azetidin-2-karboksylsyre, deres lavere alkylestere og lignende. Acyleringen av slike forbindelser er beskrevet mer i detalj senere. Compounds of formula III include, for example, proline, hydroxyproline, 4-methylproline, pipecolic acid, 5-hydroxypipecolic acid, azetidine-2-carboxylic acid, their lower alkyl esters and the like. The acylation of such compounds is described in more detail later.

Ifølge en foretrukket fremgangsmåte for fremstilling av forbindelser med formel I, spesielt hvor R_ er alkanoyl eller benzoyl, kobles en syre eller ester med formel III med en halogen-alkansyre med formelen (V): According to a preferred method for preparing compounds of formula I, especially where R_ is alkanoyl or benzoyl, an acid or ester of formula III is coupled with a haloalkanoic acid of formula (V):

hvor X er halogen, fortrinnsvis klor eller brom. Dette kan gjennomføres ved hjelp av kjente metoder der syren IV aktiveres før reaksjonen med syren III, hvilket omfatter dannelse av et blandet anhydrid, symmetrisk anhydrid, syreklorid, aktiv ester, eller bruk av Woodward reagens K, EEDQ (N-etoksykarbonyl-2-etoksy-1,2-dihydroksykinolin) eller lignende. where X is halogen, preferably chlorine or bromine. This can be carried out using known methods where the acid IV is activated before the reaction with the acid III, which includes the formation of a mixed anhydride, symmetrical anhydride, acid chloride, active ester, or the use of Woodward's reagent K, EEDQ (N-ethoxycarbonyl-2-ethoxy -1,2-dihydroxyquinoline) or the like.

Produktet fra denne reaksjon er en forbindelse med formelen (X): The product of this reaction is a compound with the formula (X):

Produktet med formel X underkastes en forflyttingsreaksjon med anionet av en tiosyre med formelen (VII): hvilket gir et produkt med formelen (XI): The product of formula X is subjected to a displacement reaction with the anion of a thioacid of formula (VII): giving a product of formula (XI):

Når R2 er alkanoyl eller benzoyl, kan dette produkt omdannes til produktet (XII): When R2 is alkanoyl or benzoyl, this product can be converted to the product (XII):

ved ammonolyse. Når R2 er en beskyttelsesgruppe, kan forbindelsen med formel XII oppnås ved "avbeskyttelse" som beskrevet ovenfor. Når R er en estergruppe (dvs. R er lavere alkoksy), by ammonolysis. When R 2 is a protecting group, the compound of formula XII can be obtained by "deprotection" as described above. When R is an ester group (ie R is lower alkoxy),

kan estergruppen fjernes, f.eks. når R er tert-butoksy eller tert-amyloksy, ved behandling av esteren med formel XI eller XII med trifluoreddiksyre og anisol slik at den tilsvarende frie syren oppnås. Når andre alkoksygrupper foreligger, vil alkalisk hydrolyse gi den tilsvarende syre. can the ester group be removed, e.g. when R is tert-butoxy or tert-amyloxy, by treating the ester of formula XI or XII with trifluoroacetic acid and anisole so that the corresponding free acid is obtained. When other alkoxy groups are present, alkaline hydrolysis will give the corresponding acid.

En variasjon av denne fremgangsmåte innbefatter bruken av en akrylsyre med formelen (VI): som utgangsmateriale. Denne akrylsyre omdannes først til syre-halogenidet, og får så reagere med en forbindelse med formel III slik at det oppnås en forbindelse med formel (XIII): A variation of this method involves the use of an acrylic acid of the formula (VI): as starting material. This acrylic acid is first converted to the acid halide, and is then allowed to react with a compound of formula III so that a compound of formula (XIII) is obtained:

og dette mellomprodukt underkastes addisjonsreaksjon med tiolen eller tiosyren VII som beskrevet ovenfor. and this intermediate is subjected to an addition reaction with the thiol or the thioacid VII as described above.

En tosyloksyalkansyre med formel (XIV): A tosyloxyalkanoic acid of formula (XIV):

kan også brukes som middel for å acylere syren med formel III, og derefter underkastes acyleringsproduktet overføringsreaksjon, osv., som beskrevet ovenfor. can also be used as the agent to acylate the acid of formula III, and then subject the acylation product to transfer reaction, etc., as described above.

Akrylsyren med formel VI kan alternativt først bringes Alternatively, the acrylic acid of formula VI can be introduced first

til reaksjon med tiosyren med formel VII slik at det oppnås et produkt med formel (XV): to reaction with the thioacid of formula VII so that a product of formula (XV) is obtained:

som omdannes til sitt syrehalogenid, f.eks. med tionylklorid, kobles med forbindelsen med formel III og den samme sekvens som ovenfor følges. which is converted to its acid halide, e.g. with thionyl chloride, is coupled with the compound of formula III and the same sequence as above is followed.

Syren eller esteren med formel III kan også acyleres med en "beskyttet" form av en u-merkaptoalkansyre med formel (XVI): The acid or ester of formula III can also be acylated with a "protected" form of a u-mercaptoalkanoic acid of formula (XVI):

hvor Rg er den "beskyttende" gruppen. Slike "beskyttelses"-grupper kan ha den form som er beskrevet ovenfor. where Rg is the "protecting" group. Such "protecting" groups may have the form described above.

Efter acyleringen kan produktet "avbeskyttes" ved hjelp av en av de kjente metoder det er henvist til ovenfor. After the acylation, the product can be "deprotected" using one of the known methods referred to above.

Enda et annet acyleringsmiddel kan ha form av et tiolakton, f.eks. (3-propiotiolakton, a-metyl-(3-propiotiolakton eller lignende. Yet another acylating agent can take the form of a thiolactone, e.g. (3-propiothiolactone, α-methyl-(3-propiothiolactone) or the like.

Ytterligere detaljer ved foretrukne fremgangsmåter for fremstilling av de nye forbindelsene kan finnes i det følgende og i de efterfølgende eksemplene. Further details of preferred methods for the preparation of the new compounds can be found in the following and in the following examples.

Ifølge en spesielt foretrukket modifikasjon acyleres syren eller esteren med formel III med et halogen-alkanoyl-halogenid med formel (XVII): According to a particularly preferred modification, the acid or ester of formula III is acylated with a halogen-alkanoyl halide of formula (XVII):

hvor hver X er et valgfritt halogenatom, fortrinnsvis klor eller brom, R^ er hydrogen, lavere alkyl eller fenyl-lavere alkyl og n er 0, 1 eller 2. Denne reaksjon gjennomføres i et alkalisk medium, f.eks. fortynnet alkalimetallhydroksydløsning, alkali-metallbikarbonat- eller alkalimetallkarbonatløsning ved en redusert temperatur, f.eks. fra ca. 0 til 15°C. Reaksjons-produktet underkastes overføringsreaksjon med anionet til tiolen eller tiosyren med formel VII ovenfor, også i alkalisk løsning, fortrinnsvis alkalimetallkarbonatløsning, og opparbeides så på vanlig måte. Produktet fra denne reaksjon, hvor R2 i formel I er alkanoyl eller benzoyl, omdannes til produktet hvor R2 er hydrogen ved ammonolyse, f.eks. med alkoholisk ammoniakk eller konsentrert ammoniumhydroksydløsning, eller alkalisk hydrolyse, f.eks. med vandig metallhydroksyd. Når det brukes en syre med formel III som startmateriale, kan det sluttprodukt som oppnås som en fri karboksylsyre omdannes til dens ester, f.eks. ved for-es tring med et diazoalkan, som f.eks. diazometan, l-alkyl-3-p-tolyl-triazen, som l-n-butyl-3-p-tolyltriazen eller lignende. Ifølge en annen variasjon behandles en ester, fortrinnsvis t-butylesteren med formel III i et vannfritt medium som f.eks. diklormetan, tetrahydrofuran, dioksan eller lignende, med en tioalkansyre med formelen (XVIII) where each X is an optional halogen atom, preferably chlorine or bromine, R 1 is hydrogen, lower alkyl or phenyl-lower alkyl and n is 0, 1 or 2. This reaction is carried out in an alkaline medium, e.g. dilute alkali metal hydroxide solution, alkali metal bicarbonate or alkali metal carbonate solution at a reduced temperature, e.g. from approx. 0 to 15°C. The reaction product is subjected to a transfer reaction with the anion of the thiol or thioacid of formula VII above, also in alkaline solution, preferably alkali metal carbonate solution, and is then worked up in the usual way. The product from this reaction, where R 2 in formula I is alkanoyl or benzoyl, is converted to the product where R 2 is hydrogen by ammonolysis, e.g. with alcoholic ammonia or concentrated ammonium hydroxide solution, or alkaline hydrolysis, e.g. with aqueous metal hydroxide. When an acid of formula III is used as starting material, the final product obtained as a free carboxylic acid can be converted to its ester, e.g. by for-es ting with a diazoalkane, such as e.g. diazomethane, 1-alkyl-3-p-tolyl triazene, such as 1-n-butyl-3-p-tolyl triazene or the like. According to another variation, an ester, preferably the t-butyl ester of formula III, is treated in an anhydrous medium such as e.g. dichloromethane, tetrahydrofuran, dioxane or the like, with a thioalkanoic acid of the formula (XVIII)

i nærvær av dicykloheksylkarbodiimid, N,N<1->karbonyl-bisimidazol, etoksyacetylen, difenylfosforylazid eller lignende koblings-midler ved temperaturer i området fra ca. 0 til 10°C. Estergruppen (R) kan så fjernes, f. eks. ved behandling med trifl.uor-eddiksyre og anisol ved omtrent romtemperatur. in the presence of dicyclohexylcarbodiimide, N,N<1->carbonyl-bisimidazole, ethoxyacetylene, diphenylphosphorylazide or similar coupling agents at temperatures in the range from approx. 0 to 10°C. The ester group (R) can then be removed, e.g. by treatment with trifluoroacetic acid and anisole at about room temperature.

Når en ester med formel III (f.eks. R er lavere alkoksy, spesielt t-butoksy) acyleres med et tiolakton, f.eks. (3-propiotiolakton, a-metyl-3-propiotiolakton eller lignende, kan reaksjonen gjennomføres i et vannfritt løsningsmiddel som f.eks. tetrahydrofuran, dioksan, metylenklorid eller lignende ved ca. When an ester of formula III (e.g. R is lower alkoxy, especially t-butoxy) is acylated with a thiolactone, e.g. (3-propiothiolactone, α-methyl-3-propiothiolactone or the like, the reaction can be carried out in an anhydrous solvent such as tetrahydrofuran, dioxane, methylene chloride or the like at approx.

0°C til omtrent romtemperatur. Estergruppen kan fjernes med anisol og trifluoreddiksyre som beskrevet ovenfor. 0°C to approximately room temperature. The ester group can be removed with anisole and trifluoroacetic acid as described above.

Produkter med formel I har ett eller flere asymmetriske karbonåtomer. Når R1, R3 eller R4 er annet enn hydrogen, er det karbonatom som de er bundet til, asymmetrisk. Disse karbonåtomer er angitt med én stjerne i formel I. Forbindelsene foreligger da i stereoisomere former eller i racemiske blandinger derav. Fremgangsmåten for fremstilling av alle disse iiggér innenfor oppfinnelsens område. Den ovenfor beskrevne syntese kan ut-nytte racematet eller en av enantiomerene som startmateriale. Når det racemiske startmaterialet brukes i syntesefremgangsmåten, kan de oppnådde stereoisomerene skilles fra hverandre ved konvensjonelle kromatografiske eller fraksjonerings-krystallisasjons-metoder. Generelt utgjør L-formen med hensyn på karbonatomet i aminosyren den foretrukne isomere formen. Også D-isomeren med hensyn på a-karbonatomet i acylsidekjeden (dvs. karbonatomet som er forbundet med R^) er foretrukket. Products of formula I have one or more asymmetric carbon atoms. When R1, R3 or R4 is other than hydrogen, the carbon atom to which they are attached is asymmetrical. These carbon atoms are indicated with one asterisk in formula I. The compounds then exist in stereoisomeric forms or in racemic mixtures thereof. The process for producing all of these lies within the scope of the invention. The synthesis described above can utilize the racemate or one of the enantiomers as starting material. When the racemic starting material is used in the synthesis process, the stereoisomers obtained can be separated from each other by conventional chromatographic or fractionation-crystallization methods. In general, the L form with regard to the carbon atom in the amino acid constitutes the preferred isomeric form. Also the D-isomer with regard to the α-carbon atom in the acyl side chain (ie the carbon atom which is connected to R^) is preferred.

Forbindelsene fremstilt ifølge oppfinnelsen danner The compounds produced according to the invention form

basiske salter med forskjellige uorganiske og organiske baser, og fremstilling av disse ligger også innenfor oppfinnelsens område« Slike salter innbefatter ammoniumsalter, alkalimetallsalter basic salts with various inorganic and organic bases, and the preparation of these is also within the scope of the invention" Such salts include ammonium salts, alkali metal salts

som f.eks. natrium- og kaliumsalter (som er foretrukket), jord-alkalimetallsalter som f.eks. kalsium- og magnesiumsalter, salter med organiske baser, f.eks. dicykloheksylaminsalt, benzatin-, N-metyl-D-glukamin- og hydrabaminsalter, salter med aminosyrer like for example. sodium and potassium salts (which are preferred), alkaline earth metal salts such as calcium and magnesium salts, salts with organic bases, e.g. dicyclohexylamine salt, benzathine, N-methyl-D-glucamine and hydrabamine salts, salts with amino acids

som f.eks. arginin, lysin og lignende. De ikke-toksiske, fysiologisk akseptable saltene er foretrukket, selv om andre salter også er brukbare, f.eks. ved isolering og rensing av produktet, slik det illustreres i eksemplene når det gjelder dicykloheksylaminsaltet. like for example. arginine, lysine and the like. The non-toxic, physiologically acceptable salts are preferred, although other salts are also useful, e.g. by isolating and purifying the product, as illustrated in the examples in the case of the dicyclohexylamine salt.

'Saltene dannes på konvensjonell måte ved å omsette den frie syreformen av produktet med en eller flere ekvivalenter av en passende base som gir det ønskede kation i et løsningsmiddel eller medium hvor saltet er uløselig, eller i vann og fjerning av 'The salts are formed in a conventional manner by reacting the free acid form of the product with one or more equivalents of a suitable base which gives the desired cation in a solvent or medium in which the salt is insoluble, or in water and removal of

vannet ved frysetørring. Ved å nøytralisere saltet med en uløselig syre som f.eks. en kationebytterharpiks i hydrogenformen (f.eks. polystyren-sulfonsyreharpiks som "Dowex 50") eller med en vandig syre og ekstraksjon med et organisk løsningsmiddel, som f.eks. etylacetat, diklormetan eller lignende, kan den frie syreformen oppnås, og om ønsket, et annet salt dannes. the water during freeze-drying. By neutralizing the salt with an insoluble acid such as a cation exchange resin in the hydrogen form (eg polystyrene sulfonic acid resin such as "Dowex 50") or with an aqueous acid and extraction with an organic solvent, such as ethyl acetate, dichloromethane or the like, the free acid form can be obtained and, if desired, another salt is formed.

Ytterligere eksperimentelle detaljer finnes i eksemplene som er foretrukne utførelsesformer og også tjener som modeller for fremstilling av andre medlemmer av gruppen. Additional experimental details are found in the examples which are preferred embodiments and also serve as models for the preparation of other members of the group.

Forbindelsene fremstilt ifølge oppfinnelsen hemmer om-dannelsen av dekapeptidet angiotensin I til angiotensin II og er derfor anvendbare for reduksjon eller lindring av angiotensin-forbundet høyt blodtrykk. Innvirkningen av enzymet renin på angiotensinogen, et pseudoglobulin i blodplasma, gir angiotensin I. Angiotensin I omdannes av det angiotensinomdannende enzym (ACE) til angiotensin II. Det sistnevnte er en aktiv trykk-substans som medvirker som forårsakende middel i forskjellige former for høyt blodtrykk hos forskjellige pattedyrarter, f.eks. rotter og hunder. Forbindelsene fremstilt ifølge oppfinnelsen intervenerer i angiotensin (renin) -» angiotensin I -» angiotensin II-sekvensen ved å hemme det angiotensinomdannende enzym og redusere eller eliminere dannelsen av trykksubstansen angiotensin II. Ved å administrere et preparat inneholdende en eller en kombinasjon av forbindelser med formel I eller fysiologisk akseptable salter derav lindres således angiotensinavhengig høyt blodtrykk hos pattedyrarter som lider derav. En enkelt dose, eller fortrinnsvis to til fire doser daglig med en mengde av ca„ 0,1 til 100 mg/kg/dag, fortrinnsvis ca„ 1 til 50 mg/kg/dag er passende for å redusere blodtrykket som angitt i dyremodellforsøkene som er beskrevet av S.L. Engel, T.R. Schaeffer, M.H. Waugh og B. Rubin, Proe. Soc. Exp. Biol. Med. 143, 483 (1973). Substansen administreres fortrinnsvis oralt, men kan også administreres parenteralt som f.eks. subkutant, intramuskulært, intravenøst eller intra-peritonealt. The compounds produced according to the invention inhibit the conversion of the decapeptide angiotensin I to angiotensin II and are therefore useful for reducing or alleviating angiotensin-related high blood pressure. The action of the enzyme renin on angiotensinogen, a pseudoglobulin in blood plasma, produces angiotensin I. Angiotensin I is converted by the angiotensin-converting enzyme (ACE) to angiotensin II. The latter is an active pressure substance that contributes as a causative agent in various forms of high blood pressure in various mammalian species, e.g. rats and dogs. The compounds produced according to the invention intervene in the angiotensin (renin)-»angiotensin I-»angiotensin II sequence by inhibiting the angiotensin-converting enzyme and reducing or eliminating the formation of the pressure substance angiotensin II. By administering a preparation containing one or a combination of compounds of formula I or physiologically acceptable salts thereof, angiotensin-dependent high blood pressure is thus alleviated in mammalian species suffering from it. A single dose, or preferably two to four doses daily at an amount of about 0.1 to 100 mg/kg/day, preferably about 1 to 50 mg/kg/day is appropriate to reduce blood pressure as indicated in the animal model studies which is described by S.L. Engel, T.R. Schaeffer, M.H. Waugh and B. Rubin, Proe. Soc. Exp. Biol. With. 143, 483 (1973). The substance is preferably administered orally, but can also be administered parenterally, e.g. subcutaneously, intramuscularly, intravenously or intra-peritoneally.

Forbindelsene fremstilt ifølge oppfinnelsen kan anvendes for å oppnå reduksjon av blodtrykk ved å lage preparater av dem, f.eks. som tabletter, kapsler eller eliksirer for oral administrasjon eller som sterile løsninger eller suspensjoner for parenteral administrasjon. Omtrent 10 til 500 mg av en forbindelse eller blanding av forbindelser med formel I eller fysiologisk akseptable salter derav blandes sammen med en fysiologisk akseptabel bærer, bindemiddel, konserveringsmiddel, stabiliseringsmiddel, smaksstoff, osv. i den doserings- The compounds produced according to the invention can be used to achieve a reduction of blood pressure by making preparations from them, e.g. as tablets, capsules or elixirs for oral administration or as sterile solutions or suspensions for parenteral administration. About 10 to 500 mg of a compound or mixture of compounds of formula I or physiologically acceptable salts thereof are mixed together with a physiologically acceptable carrier, binder, preservative, stabilizer, flavoring agent, etc. in the dosage-

enhetsform som skal anvendes i farmasøytisk praksis. Mengden aktiv substans i disse preparater er slik at det oppnås en passende dosering i det angitte område. unit form to be used in pharmaceutical practice. The amount of active substance in these preparations is such that a suitable dosage is achieved in the specified range.

Illustrerende for de hjelpemidler som kan innblandes i Illustrative of the aids that can be mixed in

tabletter, kapsler og lignende er følgende: et bindemiddel som f.eks. tragant, akasiegummi, maisstivelse eller gelatin, et bindemiddel som f.eks. dikalsiumfosfat, et disintegreringsmiddel som f.eks. maisstivelse, potetstivelse, alginsyre og lignende, tablets, capsules and the like are the following: a binder such as e.g. tragacanth, gum acacia, corn starch or gelatin, a binder such as dicalcium phosphate, a disintegrating agent such as corn starch, potato starch, alginic acid and the like,

et smøremiddel som f0eks. magnesiumstearat, et søtningsmiddel som f.eks. sukrose, laktose eller sakkarin, et smaksstoff som f„eks0 peppermynte, vintergrønnolje eller kirsebær. Når doseringsenhetsformen er en kapsel, kan den i tillegg til materialer av ovennevnte type inneholde en flytende bærer som f.eks„ en fet olje» Forskjellige andre materialer kan være til stede som belegg eller for på annen måte å modifisere den fysikalske formen på doseringsenheten. Tabletter kan eksempelvis belegges med skjellakk, sukker eller begge deler. En sirup eller eliksir kan inneholde den aktive forbindelsen, sukrose som søtningsmiddel, metyl- og propylparabener som konserveringsmidler, et farvestoff og smaksstoffer som f.eks. kirsebær- eller appelsinsmak. a lubricant such as magnesium stearate, a sweetener such as sucrose, lactose or saccharin, a flavoring such as peppermint, wintergreen oil or cherries. When the dosage unit form is a capsule, in addition to materials of the above type, it may contain a liquid carrier such as "a fatty oil". Various other materials may be present as a coating or to otherwise modify the physical form of the dosage unit. Tablets can, for example, be coated with shellac, sugar or both. A syrup or elixir may contain the active compound, sucrose as a sweetener, methyl and propyl parabens as preservatives, a coloring agent and flavorings such as e.g. cherry or orange flavor.

Sterile preparater for injeksjon kan fremstilles ifølge konvensjonell farmasøytisk praksis ved å oppløse eller suspendere den aktive substansen i en basis som f.eks. vann for injeksjon, Sterile preparations for injection can be prepared according to conventional pharmaceutical practice by dissolving or suspending the active substance in a base such as e.g. water for injection,

en naturlig forekommende vegetabilsk olje som f.eks. sesamolje, kokosnøttolje, peanøttolje, bomullsfrøolje, osv., eller en syntetisk fettbasis som f.eks. etyloleat eller, lignende. a naturally occurring vegetable oil such as sesame oil, coconut oil, peanut oil, cottonseed oil, etc., or a synthetic fat base such as ethyl oleate or, the like.

Buffere, konserveringsmidler, anti-oksydasjonsmidler og lignende kan innblandes dersom det er ønskelig. Buffers, preservatives, anti-oxidants and the like can be mixed in if desired.

Farmasøytiske verdier ble bestemt for en rekke representa-tive forbindelser fremstilt ifølge oppfinnelsen, og de fundne verdier er angitt i den følgende tabell. I^q er mengden av in-hibitor i jjg/ml som er nødvendig for å hemme aktiviteten av angiotensin-omdannende enzym med 50% som mål ved spektrofotometrisk måling. EC5q' som °9S^ betegnes som IC^Q, er den konsentrasjon av prøveforbindelsen som frembringer 50% hemning av den kontraktile virkning av angiotensin 1. Pharmaceutical values were determined for a number of representative compounds prepared according to the invention, and the values found are indicated in the following table. I^q is the amount of inhibitor in µg/ml required to inhibit the activity of angiotensin-converting enzyme by 50% as measured by spectrophotometric measurement. EC5q', which °9S^ is denoted as IC^Q, is the concentration of the test compound which produces 50% inhibition of the contractile action of angiotensin 1.

Følgende eksempler illustrerer oppfinnelsen og utgjør spesielt foretrukne utførelsesformer. Alle temperaturer er angitt i grader Celsius. The following examples illustrate the invention and constitute particularly preferred embodiments. All temperatures are given in degrees Celsius.

Eksempel 1 Example 1

1-( 2- benzoyltioacetyl)- L- prolin 1-(2-benzoylthioacetyl)-L-proline

L-prolin (5,75 g) oppløses i IN natriumhydroksyd (50 ml) og løsningen avkjøles i et isvannbad. Natriumhydroksyd 2N (26 ml) og kloracetylklorid (5,65 g) tilsettes og blandingen omrøres kraftig ved romtemperatur i tre timer„ En suspensjon av tiobenzoesyre (7,5 g) og kaliumkarbonat (4,8 g) i vann (50 ml) tilsettes, Efter 18 timers omrøring ved romtemperatur surgjøres reaksjonsblandingen og ekstraheres med etylacetat. Etylacetatskiktet vaskes med vann, tørres over magnesiumsulfat og konsentreres til tørrhet i vakuum. Residuet (14,6 g) oppløses i etylacetat (150 ml) og dicykloheksylamin (11 ml) tilsettes. Krystallene frafiltreres og omkrystalliseres fra etylacetat, utbytte 5,7 g, sm.p. 151-152°. For å omdanne saltet til syren oppløses krystallene i en L-proline (5.75 g) is dissolved in IN sodium hydroxide (50 ml) and the solution is cooled in an ice water bath. Sodium hydroxide 2N (26 ml) and chloroacetyl chloride (5.65 g) are added and the mixture is stirred vigorously at room temperature for three hours. A suspension of thiobenzoic acid (7.5 g) and potassium carbonate (4.8 g) in water (50 ml) is added. , After stirring for 18 hours at room temperature, the reaction mixture is acidified and extracted with ethyl acetate. The ethyl acetate layer is washed with water, dried over magnesium sulfate and concentrated to dryness in vacuo. The residue (14.6 g) is dissolved in ethyl acetate (150 ml) and dicyclohexylamine (11 ml) is added. The crystals are filtered off and recrystallized from ethyl acetate, yield 5.7 g, m.p. 151-152°. To convert the salt into the acid, the crystals are dissolved in a

blanding av 5%ig vandig kaliumbisulfat (100 ml) og etylacetat mixture of 5% aqueous potassium bisulphate (100 ml) and ethyl acetate

(300 ml). Den organiske fase vaskes en gang med vann, tørres (300 ml). The organic phase is washed once with water, dried

over magnesiumsulfat og konsentreres til tørrhet i vakuum>over magnesium sulfate and concentrated to dryness in vacuo>

utbytte 3,45 g, yield 3.45 g,

Eksempel 2 Example 2

1-( 2- merkaptoacetyl)- L- prolin 1-(2-mercaptoacetyl)-L-proline

1-(2-benzoyltioacetyl)-L-prolin (3,4 g) oppløses i en blanding av vann (10,5 ml) og konsentrert ammoniakk (6,4 ml), Efter en times forløp fortynnes reaksjonsblandingen med vann og filtreres..' Filtratet ekstraheres med etylacetat og surgjøres så med konsentrert saltsyre, mettes med natriumklorid og ekstraheres to ganger med etylacetat. Etylacetatekstraktene vaskes med mettet natriumkloridløsning og konsentreres til tørr-het, utbytte 1,5 g, Produktet, 1-(2-merkaptoacetyl)-L-prolin, krystalliseres fra etylacetat (sm.p. 133-135°). 1-(2-benzoylthioacetyl)-L-proline (3.4 g) is dissolved in a mixture of water (10.5 ml) and concentrated ammonia (6.4 ml). After one hour, the reaction mixture is diluted with water and filtered. The filtrate is extracted with ethyl acetate and then acidified with concentrated hydrochloric acid, saturated with sodium chloride and extracted twice with ethyl acetate. The ethyl acetate extracts are washed with saturated sodium chloride solution and concentrated to dryness, yield 1.5 g. The product, 1-(2-mercaptoacetyl)-L-proline, is crystallized from ethyl acetate (m.p. 133-135°).

Eksempel 3 Example 3

1-( 2- benzoyltiopropanoyl)- L- prolin 1-(2-benzoylthiopropanoyl)-L-proline

L-prolin (5,75 g) oppløses i vandig IN natriumhydroksyd (50 ml), og løsningen avkjøles i et isbad under omrøring. Natriumhydroksyd 2N (25 ml) og 2-brom-propionylklorid (8,57 g) tilsettes i nevnte rekkefølge og blandingen fjernes fra isbadet og omrøres ved romtemperatur i en time. En blanding av tiobenzoesyre (7,5 g) og kaliumkarbonat (4,8 g) i vann (50 ml) tilsettes og blandingen omrøres over natten ved romtemperatur. L-proline (5.75 g) is dissolved in aqueous IN sodium hydroxide (50 ml), and the solution is cooled in an ice bath with stirring. Sodium hydroxide 2N (25 ml) and 2-bromo-propionyl chloride (8.57 g) are added in the order mentioned and the mixture is removed from the ice bath and stirred at room temperature for one hour. A mixture of thiobenzoic acid (7.5 g) and potassium carbonate (4.8 g) in water (50 ml) is added and the mixture is stirred overnight at room temperature.

Efter surgjøring med konsentrert saltsyre ekstraheres den vandige løsning med etylacetat, og den organiske fase vaskes med vann, tørkes og konsentreres til tørrhet. Residuet (14,7 g) kromatograferes på en kolonne med 440 g silikagel med en blanding av benzen-eddiksyre (7:1). De fraksjoner som inneholder det ønskede materialet, samles, konsentreres til tørrhet, og residuet utfelles to ganger med eter-heksan og omdannes til et dicykloheksylaminsalt i eter-heksan, utbytte 9,4 g, sm.p. (142) 148-156°. Dicykloheksylaminsaltet tilbakedannes til syren som i eksempel 1, utbytte 5,7 g. After acidification with concentrated hydrochloric acid, the aqueous solution is extracted with ethyl acetate, and the organic phase is washed with water, dried and concentrated to dryness. The residue (14.7 g) is chromatographed on a column with 440 g of silica gel with a mixture of benzene-acetic acid (7:1). The fractions containing the desired material are collected, concentrated to dryness, and the residue precipitated twice with ether-hexane and converted to a dicyclohexylamine salt in ether-hexane, yield 9.4 g, m.p. (142) 148-156°. The dicyclohexylamine salt is reduced to the acid as in example 1, yield 5.7 g.

Eksempel 4 Example 4

1-( 2- merkaptopropanoyl)- L- prolin 1-(2-mercaptopropanoyl)-L-proline

1-(2-benzoyltiopropanoyl)-L-prolin (5,7 g) oppløses i en blanding av vann (12 ml) og konsentrert ammoniumhydroksyd (9 ml) med omrøring. Efter en times forløp fortynnes blandingen med vann (10 ml) og filtreres. Filtratet ekstraheres to ganger med etylacetat, konsentreres til en tredjedel av originalvolumet, surgjøres med konsentrert saltsyre og ekstraheres med etylacetat. Den organiske fasen vaskes med mettet natriumklorid, tørkes og konsentreres til tørrhet i vakuum. Residuet, 1-(2-merkaptopropanoyl) -L-prolin, krystalliseres fra etylacetat-heksan, utbytte 3 g, sm.p. (105) 116-120°. 1-(2-benzoylthiopropanoyl)-L-proline (5.7 g) is dissolved in a mixture of water (12 ml) and concentrated ammonium hydroxide (9 ml) with stirring. After one hour, the mixture is diluted with water (10 ml) and filtered. The filtrate is extracted twice with ethyl acetate, concentrated to one third of the original volume, acidified with concentrated hydrochloric acid and extracted with ethyl acetate. The organic phase is washed with saturated sodium chloride, dried and concentrated to dryness in vacuo. The residue, 1-(2-mercaptopropanoyl)-L-proline, is crystallized from ethyl acetate-hexane, yield 3 g, m.p. (105) 116-120°.

2L-isomeren ble fremstilt på tilsvarende måte ved acylering av L-prolin med 2-(L-acetyltio)propionsyreklorid for å danne 1-(2-L-tioacetyl-propanoyl)-L-prolin, The 2L-isomer was prepared similarly by acylation of L-proline with 2-(L-acetylthio)propionic acid chloride to form 1-(2-L-thioacetyl-propanoyl)-L-proline,

sm.p. 85-86°C, [a]^<5> -175,5° (c = 1,10, C2H50H) som derefter ble hydrolysert for å danne 2L-isomeren av tittelforbindelsen, sm.p. 85-86°C, [a]^<5> -175.5° (c = 1.10, C2H5OH) which was then hydrolyzed to form the 2L isomer of the title compound,

sm.p. (s 138) 143-144°C; [a]^<5> -63,3° (c = 1,50, CH30H). sm.p. (p 138) 143-144°C; [α]^<5> -63.3° (c = 1.50, CH 3 OH).

Eksempel 5 Example 5

1- ( 3- benzoyltiopropanoyl)- L- prolin 1-(3-benzoylthiopropanoyl)-L-proline

L-prolin (5,75 g) oppløses i normal natriumhydroksyd L-proline (5.75 g) is dissolved in normal sodium hydroxide

(50 ml) og løsningen avkjøles i et isbad. 3-brompropionyl-klorid (8,5 g) og 2N natriumhydroksyd (27 ml) tilsettes og blandingen omrøres i 10 minutter i isbadet og tre timer ved romtemperatur. En suspensjon av tiobenzoesyre (7,5 g) og kaliumkarbonat (4,5 g) i vann (50 ml) tilsettes og blandingen omrøres i 18 timer ved romtemperatur. Efter surgjøring med konsentrert saltsyre ekstraheres den vandige fase to ganger med etylacetat. De organiske skiktene tørres over magnesiumsulfat og konsentreres til tørrhet i vakuum slik at det oppnås 7,1 g, sm.p. 101-102° (50 ml) and the solution is cooled in an ice bath. 3-bromopropionyl chloride (8.5 g) and 2N sodium hydroxide (27 ml) are added and the mixture is stirred for 10 minutes in the ice bath and three hours at room temperature. A suspension of thiobenzoic acid (7.5 g) and potassium carbonate (4.5 g) in water (50 ml) is added and the mixture is stirred for 18 hours at room temperature. After acidification with concentrated hydrochloric acid, the aqueous phase is extracted twice with ethyl acetate. The organic layers are dried over magnesium sulfate and concentrated to dryness in vacuo so that 7.1 g, m.p. 101-102°

(etylacetat-heksan) av 1-(3-benzoyltiopropanoyl)-L-prolin. (ethyl acetate-hexane) of 1-(3-benzoylthiopropanoyl)-L-proline.

Eksempel 6 Example 6

1- ( 3- acetyltiopropanoyl)- L- prolin- tert- butylester L-prolin-tert-butylester (5,13 g) oppløses i diklormetan (40 ml) og løsningen avkjøles i et isvannbad. En løsning av dicykloheksylkarbodiimid (6,18 g) i diklormetan (20 ml) tilsettes, fulgt umiddelbart av 3-acetyltiopropionsyre (4,45 g). Efter 15 minutters omrøring i isvannbadet og 16 timer ved romtemperatur avfiltreres bunnfallet og filtratet konsentreres til tørrhet i vakuum. Residuet oppløses i etylacetat og vaskes nøytralt. Det organiske skiktet tørres over magnesiumsulfat og konsentreres til tørrhet i vakuum slik at det oppnås 9,8 g 1-(3-acetyltiopropanoyl)-L-prolin-tert-butylester. 1-(3-acetylthiopropanoyl)-L-proline-tert-butyl ester L-proline-tert-butyl ester (5.13 g) is dissolved in dichloromethane (40 ml) and the solution is cooled in an ice water bath. A solution of dicyclohexylcarbodiimide (6.18 g) in dichloromethane (20 mL) is added, followed immediately by 3-acetylthiopropionic acid (4.45 g). After 15 minutes of stirring in the ice water bath and 16 hours at room temperature, the precipitate is filtered off and the filtrate is concentrated to dryness in a vacuum. The residue is dissolved in ethyl acetate and washed neutrally. The organic layer is dried over magnesium sulfate and concentrated to dryness in vacuo so that 9.8 g of 1-(3-acetylthiopropanoyl)-L-proline-tert-butyl ester is obtained.

Eksempel 7 Example 7

1- ( 3- acetyltiopropanoyl)- L- prolin 1-(3-acetylthiopropanoyl)-L-proline

1-(3-acetyltiopropanoyl)-L-prolin-tert-butylester (4,7 g) oppløses i en blanding av anisol (34 ml) og trifluoreddiksyre 1-(3-acetylthiopropanoyl)-L-proline tert-butyl ester (4.7 g) is dissolved in a mixture of anisole (34 ml) and trifluoroacetic acid

(68 ml) og blandingen holdes ved romtemperatur i en time. Løsningsmidlene fjernes i vakuum og residuet utfelles fra eter-heksan flere ganger. Residuet (3,5 g) oppløses i acetonitril (68 ml) and the mixture is kept at room temperature for one hour. The solvents are removed in vacuo and the residue is precipitated from ether-hexane several times. The residue (3.5 g) is dissolved in acetonitrile

(25 ml) og dicykloheksylamin (2,8 ml) tilsettes. Det krystallinske saltet frafiltreres og omkrystalliseres fra isopropanol. Utbytte 3,8 g, sm.p. 176-177°. Saltet gjenomdannes til l-(3-acetyltiopropanoyl)-L-prolin som i eksempel 1, utbytte 1,25 g, sm.p. 89-90° (etylacetat-heksan). (25 ml) and dicyclohexylamine (2.8 ml) are added. The crystalline salt is filtered off and recrystallized from isopropanol. Yield 3.8 g, m.p. 176-177°. The salt is reconverted to l-(3-acetylthiopropanoyl)-L-proline as in example 1, yield 1.25 g, m.p. 89-90° (ethyl acetate-hexane).

Eksempel 8 Example 8

1-( 3- merkaptopropanoyl)- L- prolin- tert- butylester 1-(3-mercaptopropanoyl)-L-proline-tert-butyl ester

Til en løsning av L-prolin-tert-butylester (3,42 g) i tørt tetrahydrofuran (10 ml) avkjølt i et isbad settes propiotiolakton (1,76 g). Efter 5 minutters oppbevaring i isbadet og tre timer ved romtemperatur fortynnes reaksjonsblandingen med etylacetat (200 ml) og vaskes med 5%ig kaliumbisulfat og vann. Det organiske skiktet tørres over magnesiumsulfat og konsentreres til tørrhet i vakuum. Residuet, 1-(3-merkaptopropanoyl)-L-prolin-tert-butylester , krystalliseres fra eter-heksan, To a solution of L-proline tert-butyl ester (3.42 g) in dry tetrahydrofuran (10 ml) cooled in an ice bath is added propiothiolactone (1.76 g). After 5 minutes of storage in the ice bath and three hours at room temperature, the reaction mixture is diluted with ethyl acetate (200 ml) and washed with 5% potassium bisulphate and water. The organic layer is dried over magnesium sulfate and concentrated to dryness in vacuo. The residue, 1-(3-mercaptopropanoyl)-L-proline tert-butyl ester, is crystallized from ether-hexane,

utbytte 3,7 g, sm.p. 57-58°. yield 3.7 g, m.p. 57-58°.

Eksempel 9 Example 9

1-( 3- merkaptopropanoyl)- L- prolin 1-(3-mercaptopropanoyl)-L-proline

Fremgangsmåte A Procedure A

1-(3-benzoyltiopropanoyl)-L-prolin (4,9 g) oppløses i en blanding av vann (8 ml) og konsentrert ammoniumhydroksyd (5,6 ml) og løsningen oppbevares med omrøring under argon i en time. Reaksjonsblandingen fortynnes med vann, filtreres, og filtratet ekstraheres med etylacetat. Den vandige fasen surgjøres med konsentrert saltsyre, mettes med natriumklorid og ekstraheres med etylacetat. De organiske skiktene vaskes med mettet natriumklorid, tørres over magnesiumsulfat og konsentreres til tørrhet i vakuum. Residuet, 1-(3-merkapto-propanoyl)-L-prolin, krystalliseres fra etylacetat-heksan, utbytte 2,5 g, sm.p. 68-70°o Fremgangsmåte B 1-(3-benzoylthiopropanoyl)-L-proline (4.9 g) is dissolved in a mixture of water (8 ml) and concentrated ammonium hydroxide (5.6 ml) and the solution is kept with stirring under argon for one hour. The reaction mixture is diluted with water, filtered, and the filtrate is extracted with ethyl acetate. The aqueous phase is acidified with concentrated hydrochloric acid, saturated with sodium chloride and extracted with ethyl acetate. The organic layers are washed with saturated sodium chloride, dried over magnesium sulfate and concentrated to dryness in vacuo. The residue, 1-(3-mercapto-propanoyl)-L-proline, is crystallized from ethyl acetate-hexane, yield 2.5 g, m.p. 68-70°o Procedure B

1-(3-acetyltiopropanoyl)-L-prolin (0,8 g) oppløses i 1-(3-acetylthiopropanoyl)-L-proline (0.8 g) is dissolved in

5,5 N metanolisk ammoniakk (5 ml) og løsningen holdes under argon ved romtemperatur. Efter 2 timers forløp fjernes løsningsmidlet i vakuum, residuet oppløses i vann og påføres på en ionebytterkolonne i H+<->form ("Dowex 50" (analytisk ren)) og elueres med vann. De fraksjoner som gir tiol-positiv reaksjon samles og konsentreres til tørrhet, utbytte 0,6 g. Dette produkt krystalliseres fra etylacetat-heksan som i fremgangsmåte A og gir 1-(3-merkaptopropanoyl)-L-prolin. 5.5 N methanolic ammonia (5 ml) and the solution is kept under argon at room temperature. After 2 hours, the solvent is removed in vacuo, the residue is dissolved in water and applied to an ion exchange column in H+<-> form ("Dowex 50" (analytically pure)) and eluted with water. The fractions which give a thiol-positive reaction are collected and concentrated to dryness, yield 0.6 g. This product is crystallized from ethyl acetate-hexane as in method A and gives 1-(3-mercaptopropanoyl)-L-proline.

Fremgangsmåte C Procedure C

1-(3-merkaptopropanoyl)-L-prolin-tert-butylester (2,3 g) oppløses i en blanding av anisol (20 ml) og trifluoreddiksyre (45 ml). Efter en times oppbevaring ved romtemperatur under argon konsentreres reaksjonsblandingen til tørrhet i vakuum og residuet utfelles fra etylacetat-heksan flere ganger. Residuet (1,9 g) opp-løses i etylacetat (30 ml) og dicykloheksylamin (1,85 ml) tilsettes. Det krystallinske saltet frafiltreres og omkrystalliseres fra isopropanol, utbytte 2 g, sm.p. 187-188°. 1-(3-Mercaptopropanoyl)-L-proline tert-butyl ester (2.3 g) is dissolved in a mixture of anisole (20 ml) and trifluoroacetic acid (45 ml). After one hour's storage at room temperature under argon, the reaction mixture is concentrated to dryness in vacuo and the residue is precipitated from ethyl acetate-hexane several times. The residue (1.9 g) is dissolved in ethyl acetate (30 ml) and dicyclohexylamine (1.85 ml) is added. The crystalline salt is filtered off and recrystallized from isopropanol, yield 2 g, m.p. 187-188°.

Saltet omdannes til syren som i eksempel 1, utbytte 1,3 g. Produktet krystalliseres fra etylacetat-heksan som i fremgangsmåte A. The salt is converted to the acid as in example 1, yield 1.3 g. The product is crystallized from ethyl acetate-hexane as in method A.

Salter Salts

Natrium Sodium

1-(3-merkaptopropanoyl)-L-prolin (500 mg) oppløses i en blanding av vann (2,5 ml) og 1 N natriumhydroksyd (2,5 ml). Løsningen frysetørres for å oppnå natriumsaltet. 1-(3-mercaptopropanoyl)-L-proline (500 mg) is dissolved in a mixture of water (2.5 ml) and 1 N sodium hydroxide (2.5 ml). The solution is freeze-dried to obtain the sodium salt.

Magnesium Magnesium

1-(3-merkaptopropanoyl)-L-prolin (500 mg), magnesium-oksyd (49,5 mg) og vann (10 ml) omrøres med svak oppvarmning inntil det oppnås fullstendig oppløsning. Derefter fjernes løsningsmidlet ved frysetørring for å oppnå magnesiumsaltet. 1-(3-mercaptopropanoyl)-L-proline (500 mg), magnesium oxide (49.5 mg) and water (10 ml) are stirred with gentle heating until complete dissolution is achieved. The solvent is then removed by freeze-drying to obtain the magnesium salt.

Kalsium Calcium

1-(3-merkaptopropanoyl)-L-prolin (500 mg) oppløses i en blanding av kalsiumhydroksyd (91 mg) og vann (10 ml), og løsningen frysetørres for å oppnå kalsiumsaltet. 1-(3-mercaptopropanoyl)-L-proline (500 mg) is dissolved in a mixture of calcium hydroxide (91 mg) and water (10 ml), and the solution is freeze-dried to obtain the calcium salt.

Kalium Potassium

1-(3-merkaptopropanoyl)-L-prolin (500 mg) oppløses i en blanding av kaliumbikarbonat (246 mg) og vann (10 ml) og fryse-tørres for å oppnå kaliumsaltet. 1-(3-mercaptopropanoyl)-L-proline (500 mg) is dissolved in a mixture of potassium bicarbonate (246 mg) and water (10 ml) and freeze-dried to obtain the potassium salt.

N- metyl- D- glukamin N-methyl-D-glucamine

1-(3-merkaptopropanoyl)-L-prolin (500 mg) og N-metyl-D-glukamin (480 mg) oppløses i vann (10 ml) og frysetørres for å oppnå N-metyl-D-glukaminsaltet. 1-(3-mercaptopropanoyl)-L-proline (500 mg) and N-methyl-D-glucamine (480 mg) are dissolved in water (10 ml) and freeze-dried to obtain the N-methyl-D-glucamine salt.

Eksempel LO Example LO

1-( 3- merkaptopropanoyl)- L- hydroksyprolin 1-(3-mercaptopropanoyl)-L-hydroxyproline

Ved å anvende L-hydroksyprolin istedenfor L-prolin i fremgangsmåten i eksempel 3 og så behandle produktet ved fremgangsmåte A fra eksempel 9 oppnås 1-(3-benzoyltiopropanoyl)-L-hydroksyprolin og 1-(3-merkaptopropanoyl)-L-hydroksyprolin, sm.p. 193,5-195°C som dicykloheksylaminsalt, [a]^<5> -83,5° (c=2, metanol). By using L-hydroxyproline instead of L-proline in the method in example 3 and then treating the product by method A from example 9, 1-(3-benzoylthiopropanoyl)-L-hydroxyproline and 1-(3-mercaptopropanoyl)-L-hydroxyproline are obtained, sm.p. 193.5-195°C as dicyclohexylamine salt, [α]^<5> -83.5° (c=2, methanol).

Eksempel 11 Example 11

1-( 3- merkaptopropanoyl)- L- azetidin- 2- karboksylsyre 1-(3-mercaptopropanoyl)-L-azetidine-2-carboxylic acid

Ved å anvende L-azetidin-2-karboksylsyre-tert-butylester istedenfor L-prolin-tert-butylester i fremgangsmåten i eksempel 6, og behandle produktet som i eksempel 7 og den således oppnådde 1-(3-acetyltiopropanoyl)-L-azetidin-2-karboksylsyren som i fremgangsmåte B i eksempel 9, oppnås 1-(3-acetyltiopropanoyl)-L-azetidin-2-karboksylsyre-tert-butylester og 1-(3-merkaptopropanoyl) -L-azetidin-2-karboksylsyre respektive, sistnevnte som By using L-azetidine-2-carboxylic acid tert-butyl ester instead of L-proline tert-butyl ester in the method in example 6, and treating the product as in example 7 and the thus obtained 1-(3-acetylthiopropanoyl)-L-azetidine -2-carboxylic acid as in method B in example 9, 1-(3-acetylthiopropanoyl)-L-azetidine-2-carboxylic acid tert-butyl ester and 1-(3-mercaptopropanoyl)-L-azetidine-2-carboxylic acid are obtained respectively, the latter which

25 o 25 o

en viskøs masse, [ot]D -10,1 (c=2, etanol) . a viscous mass, [ot]D -10.1 (c=2, ethanol) .

E ksempel 12 Example 12

1-( 3- merkaptopropanoyl)- L- pipekolinsyre 1-(3-mercaptopropanoyl)-L-pipecolic acid

Ved å anvende L-pipekolinsyre-tert-butylester istedenfor L-prolin-tert-butylester i fremgangsmåten i eksempel 6 og behandle produktet efter fremgangsmåte C i eksempel 9, oppnås 1-(3-merkaptopropanoyl)-L-pipekolinsyre-tert-butylester og 1-(3-merkaptopropanoyl)-L-pipekolinsyre, respektive, sistnevnte som en viskøs masse, [a]^ -51,5° (c=l, etanol). By using L-pipecolic acid tert-butyl ester instead of L-proline tert-butyl ester in the method in example 6 and treating the product according to method C in example 9, 1-(3-mercaptopropanoyl)-L-pipecolic acid tert-butyl ester is obtained and 1-(3-mercaptopropanoyl)-L-pipecolic acid, respectively, the latter as a viscous mass, [α]^ -51.5° (c=1, ethanol).

Eksempel 13 Example 13

1-( 3- merkaptopropanoyl)- D- prolin 1-(3-mercaptopropanoyl)-D-proline

Ved å anvende D-prolin istedenfor L-prolin i fremgangsmåten fra eksempel 5 og så behandle produktet ifølge fremgangsmåte A fra eksempel 9, oppnås 1-(3-benzoyltiopropanoyl)-D-prolin og 1-(3-merkaptopropanoyl)-D-prolin, sm.p. 68-70°. By using D-proline instead of L-proline in the method from example 5 and then treating the product according to method A from example 9, 1-(3-benzoylthiopropanoyl)-D-proline and 1-(3-mercaptopropanoyl)-D-proline are obtained , sm.p. 68-70°.

Eksempel 14 Example 14

1- ( 3- acetyltio- 2- metylpropanoyl) - L- prolin- tert- butylester 1-( 3- acetylthio- 2- methylpropanoyl) - L- proline- tert-butyl ester

«L-prolin-tert-butylester (5,1 g) oppløses i diklormetan (40 ml) og løsningen omrøres og avkjøles i et isbad. Dicykloheksylkarbodiimid (6,2 g) oppløst i diklormetan (15 ml) tilsettes, umiddelbart fulgt av en løsning av 3-acetyltio-2-metylpropansyre (4,9 g) i diklormetan (5 ml). Efter 15 minutters omrøring i isbadet og 16 timer ved romtemperatur avfiltreres bunnfallet og filtratet konsentreres til tørrhet i vakuum. Residuet oppløses i etylacetat og vaskes nøytralt. Den organiske fase tørres over magnesiumsulfat og konsentreres til tørrhet i vakuum. Residuet, 1-(3-acetyltio-2-metylpropanoyl)-L-prolin-tert-butylester, renses ved kolonnekromatografi (silikagel-kloroform), utbytte 7,9 g. "L-proline tert-butyl ester (5.1 g) is dissolved in dichloromethane (40 ml) and the solution is stirred and cooled in an ice bath. Dicyclohexylcarbodiimide (6.2 g) dissolved in dichloromethane (15 ml) is added, immediately followed by a solution of 3-acetylthio-2-methylpropanoic acid (4.9 g) in dichloromethane (5 ml). After stirring for 15 minutes in the ice bath and 16 hours at room temperature, the precipitate is filtered off and the filtrate is concentrated to dryness in a vacuum. The residue is dissolved in ethyl acetate and washed neutrally. The organic phase is dried over magnesium sulfate and concentrated to dryness in vacuo. The residue, 1-(3-acetylthio-2-methylpropanoyl)-L-proline-tert-butyl ester, is purified by column chromatography (silica gel-chloroform), yield 7.9 g.

Eksempel 15 Example 15

1- ( 3- acetyltio- 2- metylpropanoyl)- L- prolin 1-(3-Acetylthio-2-methylpropanoyl)-L-proline

Fremgangsmåte A Procedure A

1-(3-acetyltio-2-metylpropanoyl)-L-prolin-tert-butylesteren fra eksempel 14 (7,8 g) oppløses i en blanding av anisol (55 ml) og trifluoreddiksyre (110 ml). Efter en times oppbevaring ved romtemperatur fjernes løsningsmidlet i vakuum og residuet utfelles flere ganger fra eter-heksan. Residuet (6,8 g) oppløses i acetonitril (40 ml) og dicykloheksylamin (4,5 ml) tilsettes. Det krystallinske saltet kokes med ny acetonitril The 1-(3-acetylthio-2-methylpropanoyl)-L-proline tert-butyl ester from Example 14 (7.8 g) is dissolved in a mixture of anisole (55 ml) and trifluoroacetic acid (110 ml). After one hour's storage at room temperature, the solvent is removed in vacuo and the residue is precipitated several times from ether-hexane. The residue (6.8 g) is dissolved in acetonitrile (40 ml) and dicyclohexylamine (4.5 ml) is added. The crystalline salt is boiled with new acetonitrile

(100 ml), avkjøles til romtemperatur og filtreres, utbytte 3,8 g, sm.p. (165) 187-188°. Dette materiale omkrystalliseres fra isopropanol ta]D -67° (c 1,4, EtOH). Det krystallinske dicykloheksylaminsaltet suspenderes i en blanding av 5%ig vandig kaliumbisulfat og etylacetat. Den organiske fase vaskes med vann og konsentreres til tørrhet. Residuet krystalliseres fra etylacetat-heksan slik at det oppnås 1-(3-acetyltio-2-D-metylpropanoyl)-L-prolin, sm.p. 83-85° [ a]* 5 -162 (c 1,7, EtOH). (100 ml), cooled to room temperature and filtered, yield 3.8 g, m.p. (165) 187-188°. This material is recrystallized from isopropanol ta]D -67° (c 1.4, EtOH). The crystalline dicyclohexylamine salt is suspended in a mixture of 5% aqueous potassium bisulphate and ethyl acetate. The organic phase is washed with water and concentrated to dryness. The residue is crystallized from ethyl acetate-hexane so that 1-(3-acetylthio-2-D-methylpropanoyl)-L-proline is obtained, m.p. 83-85° [α]* 5 -162 (c 1.7, EtOH).

Fremgangsmåte B Procedure B

3-acetyltio-2-metylpropansyre (8,1 g) og tionylklorid 3-acetylthio-2-methylpropanoic acid (8.1 g) and thionyl chloride

(7 g) blandes og suspensjonen omrøres i 16 timer ved romtemperatur. Reaksjonsblandingen konsentreres til tørrhet og destilleres i vakuum (k.p. 80°). Dette 3-acetyltio-2-metyl-propansyreklorid (5,4 g) og 2N natriumhydroksyd (15 ml) tilsettes (7 g) are mixed and the suspension is stirred for 16 hours at room temperature. The reaction mixture is concentrated to dryness and distilled in vacuo (b.p. 80°). To this 3-acetylthio-2-methyl-propanoic acid chloride (5.4 g) and 2N sodium hydroxide (15 ml) are added

til en løsning av L-prolin (3,45 g) i normal natriumhydroksyd to a solution of L-proline (3.45 g) in normal sodium hydroxide

(30 ml) avkjølt i et isvannbad. Efter 3 timers omrøring ved romtemperatur ekstraheres blandingen med eter, den vandige fase surgjøres og ekstraheres med etylacetat. Den organiske fase tørres over magnesiumsulfat og konsentreres til tørrhet slik at det oppnås 1-(3-acetyltio-2-DL-metylpropanoyl)-L-prolin. (30 ml) cooled in an ice water bath. After stirring for 3 hours at room temperature, the mixture is extracted with ether, the aqueous phase is acidified and extracted with ethyl acetate. The organic phase is dried over magnesium sulfate and concentrated to dryness so that 1-(3-acetylthio-2-DL-methylpropanoyl)-L-proline is obtained.

Fremgangsmåte C Procedure C

Metakryloylklorid (4,16 g) tilsettes til en løsning av L-prolin (3,45 g) i en blanding av vann (100 ml) og natriumbikarbonat (12 g) avkjølt i et isvannbad, med kraftig omrøring. Methacryloyl chloride (4.16 g) is added to a solution of L-proline (3.45 g) in a mixture of water (100 ml) and sodium bicarbonate (12 g) cooled in an ice water bath, with vigorous stirring.

Når tilsetningen er fullført, omrøres blandingen ved romtemperatur i to timer og ekstraheres så med eter. Den vandige fase surgjøres med IN saltsyre og ekstraheres med etylacetat. When the addition is complete, the mixture is stirred at room temperature for two hours and then extracted with ether. The aqueous phase is acidified with IN hydrochloric acid and extracted with ethyl acetate.

Den organiske fase konsentreres til tørrhet i vakuum, residuet blandes med tioleddiksyre (3,5 g), noen få azobisisobutyro-nitril-krystaller tilsettes og blandingen oppvarmes på dampbad i to timer. Reaksjonsblandingen oppløses i benzen-eddiksyre (75:25), og påføres på en kolonne med silikagel. Eluering med samme løsningsmiddel gir 1-(3-acetyltio-2-DL-metylpropanoyl)-L-prolin. The organic phase is concentrated to dryness in vacuo, the residue is mixed with thiolacetic acid (3.5 g), a few azobisisobutyronitrile crystals are added and the mixture is heated on a steam bath for two hours. The reaction mixture is dissolved in benzene-acetic acid (75:25) and applied to a column of silica gel. Elution with the same solvent gives 1-(3-acetylthio-2-DL-methylpropanoyl)-L-proline.

Eksempel 16 Example 16

1-( 3- benzoyltio- 2- D- metylpropanoyl)- L- prolin 1-(3-benzoylthio-2-D-methylpropanoyl)-L-proline

Ved å anvende 3-benzoyltio-2-D-metylpropansyre istedenfor 3-acetyltio-2-metylpropansyre i fremgangsmåten fra eksempel 14, oppnås 1-(3-benzoyltio-2-D-metylpropanoyl)-L-prolin-tert-butylester. By using 3-benzoylthio-2-D-methylpropanoic acid instead of 3-acetylthio-2-methylpropanoic acid in the method from example 14, 1-(3-benzoylthio-2-D-methylpropanoyl)-L-proline-tert-butyl ester is obtained.

Ved å anvende 1-(3-benzoyltio-2-D-metylpropanoyl)-L-prolin-tert-butylester istedenfor 1-(3-acetyltio-2-metylpropanoyl)-L-prolin-tert-butylester i fremgangsmåte A fra eksempel 15, By using 1-(3-benzoylthio-2-D-methylpropanoyl)-L-proline-tert-butyl ester instead of 1-(3-acetylthio-2-methylpropanoyl)-L-proline-tert-butyl ester in method A from example 15 ,

oppnås 1-(3-benzoyltio-2-D-metylpropanoyl)-L-prolin, 1-(3-benzoylthio-2-D-methylpropanoyl)-L-proline is obtained,

sm.p. 85-86°C (dekomp.) som et krystallinsk, farveløst fast stoff. sm.p. 85-86°C (decomp.) as a crystalline, colorless solid.

Eksempel 17 Example 17

1-( 3- merkapto- 2- D- metylpropanoyl)- L- prolin 1-(3-mercapto-2-D-methylpropanoyl)-L-proline

1-(3-merkapto-2-metylpropanoyl)-L-prolin oppnås ved å behandle produktet fra hvert av eksemplene 15 og 16 som følger: 1-(3-Mercapto-2-methylpropanoyl)-L-proline is obtained by treating the product from each of Examples 15 and 16 as follows:

Tioesteren (0,85 g) oppløses i 5,5N metanolisk ammoniakk The thioester (0.85 g) is dissolved in 5.5 N methanolic ammonia

og løsningen holdes ved romtemperatur i 2 timer. Løsningsmidlet and the solution is kept at room temperature for 2 hours. The solvent

fjernes i vakuum og residuet oppløses i vann, påføres på en ionebytterkolonne i H+<->form ("Dowex 50", analytisk rent) og elueres med vann. De fraksjoner som gir positiv tiolreaksjon samles og frysetørres. Residuet krystalliseres fra etylacetat-heksan, utbytte 0,3 g. 1-(3-merkapto-2-D-metylpropanoyl)-L-prolin har sm.p. 103-104°, [<x]D -131 (c 2, EtOH). is removed in vacuo and the residue is dissolved in water, applied to an ion exchange column in H+<-> form ("Dowex 50", analytically pure) and eluted with water. The fractions that give a positive thiol reaction are collected and freeze-dried. The residue is crystallized from ethyl acetate-hexane, yield 0.3 g. 1-(3-mercapto-2-D-methylpropanoyl)-L-proline has m.p. 103-104°, [<x]D -131 (c 2 , EtOH).

Eksempel 18 Example 18

1- ( 3- merkapto- 2- benzylpropanoyl)- L- prolin 1-(3-mercapto-2-benzylpropanoyl)-L-proline

Ved å anvende 3-acetyltio-2-benzylpropansyre istedenfor 3-acetyltio-2-metylpropansyre i fremgangsmåten fra eksempel 14 oppnås 1-(3-acetyltio-2-benzylpropanoyl)-L-prolin-tert-butylester, som derefter behandles i henhold til fremgangsmåte A fra eksempel 15 hvorved 1-(3-acetyltio-2-benzylpropanoyl)-L-prolin oppnås, og dette behandles med metanolisk ammoniakk ifølge fremgangsmåten fra eksempel 17 slik at 1-(3-merkapto-2-benzylpropanoyl)-L-prolin oppnås som en olje, R^ = 0,47 (silikagel, benzen-eddiksyre 75:25). By using 3-acetylthio-2-benzylpropanoic acid instead of 3-acetylthio-2-methylpropanoic acid in the method from example 14, 1-(3-acetylthio-2-benzylpropanoyl)-L-proline-tert-butyl ester is obtained, which is then treated according to method A from example 15 whereby 1-(3-acetylthio-2-benzylpropanoyl)-L-proline is obtained, and this is treated with methanolic ammonia according to the method from example 17 so that 1-(3-mercapto-2-benzylpropanoyl)-L- proline is obtained as an oil, R^ = 0.47 (silica gel, benzene-acetic acid 75:25).

Eksempel 19 Example 19

1-( 3- merkapto- 2- metylpropanoyl)- L- hydroksyprolin 1-(3-mercapto-2-methylpropanoyl)-L-hydroxyproline

Ved å anvende L-hydroksyprolin-tert-butylester i fremgangsmåten fra eksempel 14, behandle produktet ifølge fremgangsmåte A fra eksempel 15 og så fortsette som i eksempel 17, oppnås 1-(3-acetyltio-2-metylpropanoyl)-L-hydroksyprolin-tert-butylester, 1-(3-acetyltio-2-metylpropanoyl)-L-hydroksyprolin og l-(3-merkapto-2-metylpropanoyl)-L-hydroksyprolin, respektive, tittelproduktet som et hygroskopisk, fast stoff, [&]^ -114° (c=l, metanol). By using L-hydroxyproline tert-butyl ester in the method from example 14, treating the product according to method A from example 15 and then continuing as in example 17, 1-(3-acetylthio-2-methylpropanoyl)-L-hydroxyproline-tert is obtained -butyl ester, 1-(3-acetylthio-2-methylpropanoyl)-L-hydroxyproline and 1-(3-mercapto-2-methylpropanoyl)-L-hydroxyproline, respectively, the title product as a hygroscopic solid, [&]^ - 114° (c=1, methanol).

Eksempel 20 Example 20

1- ( 3- merkapto- 2- metylpropanoyl)- L- pipekolinsyre 1-(3-mercapto-2-methylpropanoyl)-L-pipecolic acid

Ved å substituere L-pipekolinsyre i fremgangsmåten fra eksempel 15, behandle produktet ifølge fremgangsmåte A fra eksempel 16 og så fortsette som i eksempel 17, oppnås l-(3-acetyltio-2-metylpropanoyl)-L-pipekolinsyre-tert-butylester, 1- (3-acetyltio-2-metylpropanoyl)-L-pipekolinsyre og 1-(3-merkapto-2- metylpropanoyl)-L-pipekolinsyre, respektive. Tittelproduktet oppnås som 2-D-metyl-isomeren, sm.p. 85-90°C, [ot]^ -88° (c=l, By substituting L-pipecolic acid in the method from example 15, treating the product according to method A from example 16 and then continuing as in example 17, l-(3-acetylthio-2-methylpropanoyl)-L-pipecolic acid tert-butyl ester is obtained, 1 - (3-acetylthio-2-methylpropanoyl)-L-pipecolic acid and 1-(3-mercapto-2-methylpropanoyl)-L-pipecolic acid, respectively. The title product is obtained as the 2-D-methyl isomer, m.p. 85-90°C, [ot]^ -88° (c=l,

etanol). 2-L-metyl-isomeren gjenvinnes fra moderluten som et ethanol). The 2-L-methyl isomer is recovered from the mother liquor as a

25 o 25 o

viskøst stoff, [alD = 33 (c=l, etanol). viscous substance, [alD = 33 (c=1, ethanol).

E ksempel 21 Example 21

1-( 4- benzoyltiobutanoyl)- L- prolin 1-(4-benzoylthiobutanoyl)-L-proline

Til en løsning av L-prolin (2,88 g) i normal natriumhydroksyd (25 ml) avkjølt i et isbad tilsettes 2N natriumhydroksyd (12,5 ml) og 4-klorbutyrylklorid (3,5 g). Reaksjonsblandingen omrøres ved romtemperatur i 3,5 timer og en suspensjon av tiobenzoesyre (3,75 g) og kaliumkarbonat (2,4 g) i vann (25 ml) tilsettes. Efter omrøring over natten ved romtemperatur surgjøres reaksjonsblandingen med konsentrert saltsyre og ekstraheres med etylacetat„ Det organiske skiktet tørres over magnesiumsulfat og konsentreres til tørrhet i vakuum. Residuet kromatograferes på en kolonne av silikagel med benzen-eddiksyre (7:1). De fraksjoner som inneholder det ønskede materiale samles og konsentreres til tørrhet, utbytte 1,35 g. En liten alikvot av dette materiale oppløses i etylacetat og dicykloheksylamin tilsettes inntil pH 8-10 (på vått pH-papir). Dicykloheksylaminsaltet utkrystalliserer straks, sm.p. 159-161°. To a solution of L-proline (2.88 g) in normal sodium hydroxide (25 ml) cooled in an ice bath are added 2N sodium hydroxide (12.5 ml) and 4-chlorobutyryl chloride (3.5 g). The reaction mixture is stirred at room temperature for 3.5 hours and a suspension of thiobenzoic acid (3.75 g) and potassium carbonate (2.4 g) in water (25 ml) is added. After stirring overnight at room temperature, the reaction mixture is acidified with concentrated hydrochloric acid and extracted with ethyl acetate. The organic layer is dried over magnesium sulfate and concentrated to dryness in vacuo. The residue is chromatographed on a column of silica gel with benzene-acetic acid (7:1). The fractions containing the desired material are collected and concentrated to dryness, yield 1.35 g. A small aliquot of this material is dissolved in ethyl acetate and dicyclohexylamine is added until pH 8-10 (on wet pH paper). The dicyclohexylamine salt crystallizes out immediately, m.p. 159-161°.

E ksempel 2 2 E xample 2 2

1-( 4- merkaptobutanoyl)- L- prolin 1-(4-mercaptobutanoyl)-L-proline

1-(4-benzyltiobutanoyl)-L-prolin (1,08 g) oppløses i en blanding av vann (4 ml) og konsentrert ammoniakk (2,7 ml). Efter en times omrøring ved romtemperatur fortynnes blandingen med vann, filtreres, ekstraheres med etylacetat og den vandige fasen konsentreres i vakuum. Dette ammoniumsaltet av 1-(4-merkapto-butanoyl) -L-prolin renses ved ionebytterkromatografi på en kolonne med dietylaminoetyl-"Sephadex" (tverrbundet dekstran) 1-(4-Benzylthiobutanoyl)-L-proline (1.08 g) is dissolved in a mixture of water (4 ml) and concentrated ammonia (2.7 ml). After stirring for one hour at room temperature, the mixture is diluted with water, filtered, extracted with ethyl acetate and the aqueous phase is concentrated in vacuo. This ammonium salt of 1-(4-mercapto-butanoyl)-L-proline is purified by ion exchange chromatography on a column of diethylaminoethyl "Sephadex" (cross-linked dextran)

med en gradient av ammoniumbikarbonat, utbytte 0,7 g. Ammoniumsaltet oppløses i vann (2 ml) og påføres på en kolonne med "Dowex 50" sulfonsyreharpiks av analytisk renhet i hydrogenform, og den frie syren elueres med vann. De fraksjoner som inneholder det ønskede materialet (sulfhydrylreagens- og karboksylreagens-positive) samles og frysetørres slik at det oppnås 1-(4-merkapto-butanoyl) -L-prolin. Dicykloheksylammoniumsaltet fremstilles ifølge fremgangsmåten fra eksempel 21, sm.p. 157-158°. with a gradient of ammonium bicarbonate, yield 0.7 g. The ammonium salt is dissolved in water (2 ml) and applied to a column of "Dowex 50" sulphonic acid resin of analytical grade in hydrogen form, and the free acid is eluted with water. The fractions containing the desired material (sulfhydryl reagent and carboxyl reagent positive) are collected and freeze-dried so that 1-(4-mercapto-butanoyl)-L-proline is obtained. The dicyclohexylammonium salt is prepared according to the method from example 21, m.p. 157-158°.

Eksempel 2 3 Example 2 3

1-( 3- acetyltiobutanoyl)- L- prolin- tert- butylester 1-(3-acetylthiobutanoyl)-L-proline-tert-butyl ester

Dicykloheksylkarbodiimid (6,2 g) og 3-acetyltiosmørsyre (4,86 g) tilsettes til en løsning av L-prolin-tert-butylester (5,1 g) i diklormetan (60 ml) omrørt i et isbad. Efter 15 minutter fjernes isbadet og blandingen omrøres ved romtemperatur i 16 timer. Bunnfallet frafiltreres, filtratet konsentreres til tørrhet og residuet kromatograferes på en kolonne- av silikagel med kloroform for å oppnå 1-(3-acetyltiobutanoyl)-L-prolin-tert-butylester, utbytte 5,2 g. Dicyclohexylcarbodiimide (6.2 g) and 3-acetylthiobutyric acid (4.86 g) are added to a solution of L-proline tert-butyl ester (5.1 g) in dichloromethane (60 ml) stirred in an ice bath. After 15 minutes, the ice bath is removed and the mixture is stirred at room temperature for 16 hours. The precipitate is filtered off, the filtrate is concentrated to dryness and the residue is chromatographed on a column of silica gel with chloroform to obtain 1-(3-acetylthiobutanoyl)-L-proline-tert-butyl ester, yield 5.2 g.

Eksempel 2 4 Example 2 4

1-( 3- acetyltiobutanoyl)- L- prolin 1-(3-acetylthiobutanoyl)-L-proline

1-(3-acetyltiobutanoyl)-L-prolin-tert-butylesteren fra eksempel 23 (5,2 g) oppløses i en blanding av trifluoreddiksyre (60 ml) og anisol (30 ml) og løsningen holdes ved romtemperatur i en time. Løsningsmidlene fjernes i vakuum, og det gjenværende 1-(3-acetyltiobutanoyl)-L-prolin utfelles fra eter-heksan flere ganger, utbytte 4 g. Dicykloheksylaminsaltet fremstilles ifølge fremgangsmåten fra eksempel 21, sm.p. 175-176°. The 1-(3-acetylthiobutanoyl)-L-proline tert-butyl ester from example 23 (5.2 g) is dissolved in a mixture of trifluoroacetic acid (60 ml) and anisole (30 ml) and the solution is kept at room temperature for one hour. The solvents are removed in vacuo, and the remaining 1-(3-acetylthiobutanoyl)-L-proline is precipitated from ether-hexane several times, yield 4 g. The dicyclohexylamine salt is prepared according to the method from example 21, m.p. 175-176°.

Eksempel 2 5 Example 2 5

1-( 3- merkaptobutanoyl)- L- prolin 1-(3-mercaptobutanoyl)-L-proline

1-(3-acetyltiobutanoyl)-L-prolinet fra eksempel 24 The 1-(3-acetylthiobutanoyl)-L-proline from Example 24

(0,86 g) oppløses i 5,5N metanolisk ammoniakk (20 ml) og reaksjonsblandingen oppbevares ved romtemperatur i to timer. Løsnings-midlet fjernes i vakuum og residuet kromatograferes på en ionebytterkolonne ("Dowex 50") med vann. De fraksjoner som inneholder det ønskede 1-(3-merkaptobutanoyl)-L-prolin samles og lyofiliseres, utbytte 0,6 g. Dicykloheksylaminsaltet fremstilles ifølge fremgangsmåten fra eksempel 21, sm.p. 183-184°. (0.86 g) is dissolved in 5.5N methanolic ammonia (20 ml) and the reaction mixture is kept at room temperature for two hours. The solvent is removed in vacuo and the residue is chromatographed on an ion exchange column ("Dowex 50") with water. The fractions containing the desired 1-(3-mercaptobutanoyl)-L-proline are collected and lyophilized, yield 0.6 g. The dicyclohexylamine salt is prepared according to the method from example 21, m.p. 183-184°.

Eksempel 2 6 Example 2 6

1- ( benzyltioacetyl)- L- prolin 1-(benzylthioacetyl)-L-proline

Ved å omsette benzyltioacetylklorid med L-prolin i en By reacting benzylthioacetyl chloride with L-proline in a

IN natriumhydroksydløsning med avkjøling oppnås 1-(benzyltio-acetyl) -L-prolin , sm.p. 86-88°. IN sodium hydroxide solution with cooling, 1-(benzylthio-acetyl)-L-proline is obtained, m.p. 86-88°.

Eksempel 2 7 Example 2 7

1-( 3- merkapto- 2- fenylpropanoyl)- L- prolin 1-(3-mercapto-2-phenylpropanoyl)-L-proline

Ved å anvende 3-acetyltio-2-fenylpropansyre istedenfor 3-acetyltio-2-metylpropansyre i fremgangsmåten fra eksempel 14 oppnås 1-(3-acetyltio-2-fenylpropanoy1)-L-prolin-tert-butylester. By using 3-acetylthio-2-phenylpropanoic acid instead of 3-acetylthio-2-methylpropanoic acid in the method from example 14, 1-(3-acetylthio-2-phenylpropanoyl)-L-proline-tert-butyl ester is obtained.

Ved å anvende 1-(3-acetyltio-2-fenylpropanoyl)-L-prolin-tert-butylester istedenfor 1-(3-acetyltio-2-metylpropanoyl-L-prolin-tert-butylester i fremgangsmåten fra eksempel 15, og underkaste produktet ammonolyse som i eksempel 17, oppnås l-(3-acetyltio-2-fenylpropanoyl)-L-prolin og 1-(3-merkapto-2-fenyl-propanoyl)-L-prolin. Tittelproduktet har sm.p. 49-52°C og By using 1-(3-acetylthio-2-phenylpropanoyl)-L-proline-tert-butyl ester instead of 1-(3-acetylthio-2-methylpropanoyl-L-proline-tert-butyl ester in the method from example 15, and subjecting the product ammonolysis as in example 17, 1-(3-acetylthio-2-phenylpropanoyl)-L-proline and 1-(3-mercapto-2-phenyl-propanoyl)-L-proline are obtained. The title product has m.p. 49-52 °C and

[a]j^ +2,5° (c=l, etanol). [a]j^ +2.5° (c=1, ethanol).

Eksempel 2 8 Example 2 8

1-[ 3- ( acetyltio)- DL- propanoyl]- pipekolinsyre 1-[3-(acetylthio)-DL-propanoyl]-pipecolic acid

Pipekolinsyre (6,5 g) suspenderes i 200 ml dimetylacetamid. 3-acetyltiopropanoylklorid (8,3 g) tilsettes dråpevis ved 2 3° til suspensjonen. Det dannes en klar løsning og temperaturen stiger til 28°. Til denne klare løsning tilsettes N-metylmorfolin (10,1 g). Det dannes straks et bunnfall og temperaturen stiger til 34°. Blandingen oppvarmes på et dampbad i 1 time da det dannes en klar løsning. Efter avkjøling avfiltreres det utfelte faste stoff og gir 5,1 g 1-[3-(acetyltio)-DL-propanoyl]-pipekolinsyre, sm.p. 190-200°. Løsningsmidlet fjernes og den viskøse resten utgnis med isopropyleter slik at det oppnås 7,8 g av et produkt som smelter ved 98-101°. Omkrystallisasjon fra aceton-heksan gir et konstant smeltende, fast stoff, Pipecolic acid (6.5 g) is suspended in 200 ml of dimethylacetamide. 3-acetylthiopropanoyl chloride (8.3 g) is added dropwise at 2 3° to the suspension. A clear solution is formed and the temperature rises to 28°. N-methylmorpholine (10.1 g) is added to this clear solution. A precipitate immediately forms and the temperature rises to 34°. The mixture is heated on a steam bath for 1 hour when a clear solution is formed. After cooling, the precipitated solid is filtered off and gives 5.1 g of 1-[3-(acetylthio)-DL-propanoyl]-pipecolic acid, m.p. 190-200°. The solvent is removed and the viscous residue is triturated with isopropyl ether so that 7.8 g of a product melting at 98-101° is obtained. Recrystallization from acetone-hexane gives a constant melting solid,

sm.p. 102-104°; Rf 0,72 (silikagel, benzen, eddiksyre (7:2). sm.p. 102-104°; Rf 0.72 (silica gel, benzene, acetic acid (7:2).

Eksempel 29 Example 29

DL- 1-( 3- merkaptopropanoyl) pipekolinsyre DL- 1-(3- mercaptopropanoyl) pipecolic acid

12 ml konsentrert ammoniumhydroksyd omrøres under nitrogen ved 10° i ca. 15 minutter, så tilsettes fast 1-[3-(acetyltio)-DL-propanoyl]-pipekolinsyre (6,6 g) ved 5 til 10°. Det dannes 12 ml of concentrated ammonium hydroxide are stirred under nitrogen at 10° for approx. 15 minutes, then solid 1-[3-(acetylthio)-DL-propanoyl]-pipecolic acid (6.6 g) is added at 5 to 10°. It is formed

en klar løsning efter 2-3 minutters forløp. Isbadet fjernes og løsningen omrøres ved romtemperatur under nitrogen i 45 minutter. Løsningen gjøres sterkt sur med 20%ig HC1 (avkjøling), og den utfelte olje ekstraheres med 3 x 150 ml etylacetat. Etylacetatekstraktene tørres over magnesiumsulfat og løsningsmidlet fjernes a clear solution after 2-3 minutes. The ice bath is removed and the solution is stirred at room temperature under nitrogen for 45 minutes. The solution is made strongly acidic with 20% HCl (cooling), and the precipitated oil is extracted with 3 x 150 ml of ethyl acetate. The ethyl acetate extracts are dried over magnesium sulfate and the solvent is removed

slik at det oppnås 6,0 g DL-1-(3-merkaptopropanoyl)pipekolinsyre, Rf 0,77 (silikagel, benzen, eddiksyre (7:1)). so that 6.0 g of DL-1-(3-mercaptopropanoyl)pipecolic acid is obtained, Rf 0.77 (silica gel, benzene, acetic acid (7:1)).

Eksempel 30 Example 30

1-( 3- merkaptopropanoyl)- L- pipekolinsyre 1-(3-mercaptopropanoyl)-L-pipecolic acid

Ved å anvende L-pipekolinsyre istedenfor DL-pipekolinsyre i fremgangsmåten fra eksempel 28 og så underkaste produktet fremgangsmåten i eksempel 29 oppnås 1-[3-(acetyltio)propanoyl]-L-pipekolinsyre og 1-(3-merkaptopropanoyl)-L-pipekolinsyre, By using L-pipecolic acid instead of DL-pipecolic acid in the method from example 28 and then subjecting the product to the method in example 29, 1-[3-(acetylthio)propanoyl]-L-pipecolic acid and 1-(3-mercaptopropanoyl)-L-pipecolic acid are obtained ,

20 20

Rf 0,80 (silikagel, benzen, eddiksyre (7:1)), [a]p -51,5 (c 1,0, abs. etanol). Rf 0.80 (silica gel, benzene, acetic acid (7:1)), [α]p -51.5 (c 1.0, abs. ethanol).

Eksempel 31 Example 31

1-[ 3-( acetyltio)- 2- metylpropanoyl- DL- pipekolinsyre 1-[ 3-( acetylthio)- 2- methylpropanoyl- DL- pipecolic acid

6,5 g (0,05 m) pipekolinsyre suspenderes i dimetylacetamid (200 ml), 9,0 g (0,05 m) 3-acetyltio-2-metylpropanoy1-klorid tilsettes dråpevis. Temperaturen stiger til 29° og det dannes en klar løsning. Så tilsettes på en gang 10,1 g N-metylmorfolin og temperaturen stiger til 34°. Blandingen oppvarmes på et dampbad i 1 time da det dannes en klar løsning. Denne får stå over natten ved romtemperatur, og det faste stoff som faller ut, filtreres slik at det oppnås 6,1 g, sm.p. 203-204°. Løsningsmidlet fjernes og den viskøse resten utgnis med vann og 20%ig HC1. Den gule oljen ekstraheres med 3 x 150 ml etylacetat. Etylacetatekstraktene tørres over magnesiumsulfat og fjernes slik at det oppnås 14 g 1-[3-(acetyltio)-2-metylpropanoyl-DL-pipekolinsyre som en viskøs olje. 6.5 g (0.05 m) of pipecolic acid is suspended in dimethylacetamide (200 ml), 9.0 g (0.05 m) of 3-acetylthio-2-methylpropanoyl chloride is added dropwise. The temperature rises to 29° and a clear solution is formed. Then 10.1 g of N-methylmorpholine are added at once and the temperature rises to 34°. The mixture is heated on a steam bath for 1 hour when a clear solution is formed. This is allowed to stand overnight at room temperature, and the solid which precipitates is filtered so that 6.1 g, m.p. 203-204°. The solvent is removed and the viscous residue is triturated with water and 20% HCl. The yellow oil is extracted with 3 x 150 ml of ethyl acetate. The ethyl acetate extracts are dried over magnesium sulfate and removed so that 14 g of 1-[3-(acetylthio)-2-methylpropanoyl-DL-pipecolic acid is obtained as a viscous oil.

Eksempel 32 Example 32

1-( 3- merkapto- 2- metylpropanoyl)- DL- pipekolinsyre 1-(3-mercapto-2-methylpropanoyl)-DL-pipecolic acid

Vandig NH^OH (30 ml vann og 20 ml kons. NH^OH) omrøres under nitrogen ved 10° i 15 minutter. Denne tilsettes til 13,0 g (0,05 m) 1-[3-(acetyltio)-2-metylpropanoyl]-DL-pipekolinsyre Aqueous NH^OH (30 ml water and 20 ml conc. NH^OH) is stirred under nitrogen at 10° for 15 minutes. This is added to 13.0 g (0.05 m) of 1-[3-(acetylthio)-2-methylpropanoyl]-DL-pipecolic acid

og den resulterende løsning omrøres i 10 minutter under nitrogen og så véd romtemperatur i 50 minutter. Den behandles så med vann og 20%ig HC1 og den gule oljen ekstraheres med 3 x 150 ml etylacetat. Etylacetatekstraktene tørres over magnesiumsulfat og and the resulting solution is stirred for 10 minutes under nitrogen and then at room temperature for 50 minutes. It is then treated with water and 20% HCl and the yellow oil is extracted with 3 x 150 ml of ethyl acetate. The ethyl acetate extracts are dried over magnesium sulfate and

fjernes slik at det oppnås 11,1 g 1- (3-merkapto-2-metylpropanoyl)-DL-pipekolinsyre som en viskøs olje. Rf 0,62 (silikagel, benzen, eddiksyre (7:2)). is removed so that 11.1 g of 1-(3-mercapto-2-methylpropanoyl)-DL-pipecolic acid is obtained as a viscous oil. Rf 0.62 (silica gel, benzene, acetic acid (7:2)).

Eksempel 33 Example 33

1-( 3- merkapto- 2- metylpropanoyl)- L- prolin 1-(3-mercapto-2-methylpropanoyl)-L-proline

p-metoksy-a-toluen-tiol (15,4 g, 0,1 mol) tilsettes til p-Methoxy-α-toluene-thiol (15.4 g, 0.1 mol) is added to

en løsning av metakrylsyre (8,6 g, 0,1 mol) i 50 ml 2N natriumhydroksyd. Blandingen oppvarmes på et dampbad i tre timer og tilbakeløpsbehandles i to timer og avkjøles. Blandingen ekstraheres med eter, det vandige skiktet surgjøres så med konsentrert HC1 og ekstraheres med diklormetan. De sure ekstraktene vaskes med saltløsning, tørres (MgSO^) og fordampes i vakuum. Det resulterende halv-faste stoff opptas i 50 ml diklormetan, fortynnes med 50 ml heksan og avkjøles. 3-[(4-metoksyfenyl)-metyltio]-2-metylpropansyre oppsamles som et hvitt, krystallinsk fast stoff, sm.p. 74-82° (5,5 g). a solution of methacrylic acid (8.6 g, 0.1 mol) in 50 ml of 2N sodium hydroxide. The mixture is heated on a steam bath for three hours and refluxed for two hours and cooled. The mixture is extracted with ether, the aqueous layer is then acidified with concentrated HCl and extracted with dichloromethane. The acidic extracts are washed with saline, dried (MgSO4) and evaporated in vacuo. The resulting semi-solid is taken up in 50 ml of dichloromethane, diluted with 50 ml of hexane and cooled. 3-[(4-Methoxyphenyl)-methylthio]-2-methylpropanoic acid is collected as a white, crystalline solid, m.p. 74-82° (5.5 g).

3-[(4-metoksyfenyl)metyltio]-2-metylpropansyre (3,6 g, 0,015 mol), L-prolin-tert-butylester (2,6 g, 0,015 mol) og dicykloheksylkarbodiimid (3,1 g, 0,015 mol) oppløses i 50 ml diklormetan og omrøres i 30 minutter ved 0°. Kjølebadet fjernes og blandingen omrøres over natten (16 timer). Den resulterende suspensjon filtreres og filtratet vaskes med 5%ig kaliumbisulfat, mettet natriumbikarbonat og saltløsning, tørres så (MgSO^) og inndampes i vakuum. Den resulterende klare olje påføres på en 250 ml silikagelkolonne og kromatograferes ved å bruke 20% etylacetat/heksan som elueringsmiddel. Hovedfraksjonen (Rf = 0,70, silikagel, etylacetat) inndampes til 5,5 g (9 3%) l-[3-(4-metoksyfenyl)metyltio]-2-metylpropanoyl-L-prolin-tert-butylester som en klar olje. Rf = 0,70 (silikagel, etylacetat); Rf = 0,60 (silikagel, eter). 3-[(4-Methoxyphenyl)methylthio]-2-methylpropanoic acid (3.6 g, 0.015 mol), L-proline tert-butyl ester (2.6 g, 0.015 mol) and dicyclohexylcarbodiimide (3.1 g, 0.015 mol ) is dissolved in 50 ml of dichloromethane and stirred for 30 minutes at 0°. The cooling bath is removed and the mixture is stirred overnight (16 hours). The resulting suspension is filtered and the filtrate is washed with 5% potassium bisulfate, saturated sodium bicarbonate and brine, then dried (MgSO 4 ) and evaporated in vacuo. The resulting clear oil is applied to a 250 ml silica gel column and chromatographed using 20% ethyl acetate/hexane as eluent. The main fraction (Rf = 0.70, silica gel, ethyl acetate) is evaporated to 5.5 g (9 3%) of 1-[3-(4-methoxyphenyl)methylthio]-2-methylpropanoyl-L-proline-tert-butyl ester as a clear oil. Rf = 0.70 (silica gel, ethyl acetate); Rf = 0.60 (silica gel, ether).

Den sistnevnte ester (1,2 g, 0,003 mol), anisol (5 ml) The latter ester (1.2 g, 0.003 mol), anisole (5 ml)

og trifluormetansulfonsyre (0,5 ml) oppløses i 20 ml trifluoreddiksyre under nitrogen, og den resulterende røde løsning fikk stå en time ved romtemperatur. Løsningen inndampes i vakuum til et rødt residuum som opptas i etylacetat og vaskes med vann, saltløsning, tørres så (MgSO^) og inndampes. Residuet utgnis gjentatte ganger med heksan og resterende heksan fordampes. Oljeresten oppgår til 0,4 g. En porsjon (180 mg) av dette and trifluoromethanesulfonic acid (0.5 ml) were dissolved in 20 ml of trifluoroacetic acid under nitrogen, and the resulting red solution was allowed to stand for one hour at room temperature. The solution is evaporated in vacuo to a red residue which is taken up in ethyl acetate and washed with water, brine, then dried (MgSO4) and evaporated. The residue is triturated repeatedly with hexane and the remaining hexane is evaporated. The oil residue amounts to 0.4 g. One portion (180 mg) of this

materiale underkastes preparativ tynnskiktskromatografi på 2 mm silikagelplater ved å bruke benzen/eddiksyre 75:25 som elueringsmiddel. Det nitroprussid-positive hovedbåndet (Rf = 0,40) ut-vinnes og gir 135 mg 1-(3-merkapto-2-metylpropanoyl)-L-prolin som en olje. TLC ved bruk av benzen/eddiksyre 75:25 (Rf = 0,40) og kloroform/metanol/eddiksyre 50:40:10 (Rf = 0,62). material is subjected to preparative thin-layer chromatography on 2 mm silica gel plates using benzene/acetic acid 75:25 as eluent. The major nitroprusside-positive band (Rf = 0.40) is recovered to give 135 mg of 1-(3-mercapto-2-methylpropanoyl)-L-proline as an oil. TLC using benzene/acetic acid 75:25 (Rf = 0.40) and chloroform/methanol/acetic acid 50:40:10 (Rf = 0.62).

Eksempel 34 Example 34

1-( 3- merkapto- 2- D- metylpropanoyl)- L- prolin 1-(3-mercapto-2-D-methylpropanoyl)-L-proline

Under et argonteppe oppslemmes 1-[3-(acetyltio)-2-D-mety1-propanoyl]-L-prolin (10,0 g) i vann (150 ml) ved 10°. Til denne blanding tilsettes 5N natriumhydroksyd, og pH i løsningen holdes på 13 i 1,5 timer. Efter denne tid, når det ikke opptas mer natriumhydroksyd, surgjøres løsningen til pH 2,0 med konsentrert svovelsyre. Under an argon blanket, 1-[3-(acetylthio)-2-D-methyl-propanoyl]-L-proline (10.0 g) is slurried in water (150 ml) at 10°. 5N sodium hydroxide is added to this mixture, and the pH of the solution is kept at 13 for 1.5 hours. After this time, when no more sodium hydroxide is absorbed, the solution is acidified to pH 2.0 with concentrated sulfuric acid.

Den vandige løsningen ekstraheres så tre ganger med metylenklorid (3 x 150 ml) og de kombinerte metylenklorid-fraksjoner konsentreres til en olje. Konsentratet opptas i etylacetat, filtreres og filtratet fortynnes med heksan (30 ml). The aqueous solution is then extracted three times with methylene chloride (3 x 150 ml) and the combined methylene chloride fractions are concentrated to an oil. The concentrate is taken up in ethyl acetate, filtered and the filtrate is diluted with hexane (30 ml).

En ytterligere mengde heksan tilsettes efter 1/2 times forløp, A further amount of hexane is added after 1/2 hour,

og blandingen avkjøles så til 10° i en time. and the mixture is then cooled to 10° for one hour.

Krystallene frafiltreres og vaskes med heksan (2 x 25 ml) og tørres til konstant vekt for å gi 1-(3-merkapto-2-D-mety1-propanoyl)-L-prolin som hvite krystaller, 6,26 g, sm.p. 100-102°. The crystals are filtered off and washed with hexane (2 x 25 mL) and dried to constant weight to give 1-(3-mercapto-2-D-methyl-propanoyl)-L-proline as white crystals, 6.26 g, sm. p. 100-102°.

Eksempel 35 Example 35

1-( 3- acetyltio- 2- metylpropanoyl)- L- prolin 1-(3-Acetylthio-2-methylpropanoyl)-L-proline

1-(3-tosyloksy-2-metylpropanoyl)-L-prolin (3,5 g) tilsettes til en løsning av tioleddiksyre (1,14 g) og trietylamin (3,5 ml) i etylacetat (20 ml). Løsningen holdes ved 50° i tre timer, avkjøles, fortynnes med etylacetat (100 ml) og vaskes med fortynnet saltsyre. Det organiske skiktet tørres og konsentreres til tørrhet i vakuum. Residuet oppløses i acetonitril og dicykloheksylamin tilsettes. Det krystallinske bunnfallet omkrystalliseres fra isopropanol og gir 1-(3-acetyltio-2-D-metylpropanoyl)-L-prolin-dicykloheksylaminsalt, sm.p. 187-188°, 1-(3-Tosyloxy-2-methylpropanoyl)-L-proline (3.5 g) is added to a solution of thiolacetic acid (1.14 g) and triethylamine (3.5 ml) in ethyl acetate (20 ml). The solution is kept at 50° for three hours, cooled, diluted with ethyl acetate (100 ml) and washed with dilute hydrochloric acid. The organic layer is dried and concentrated to dryness in vacuo. The residue is dissolved in acetonitrile and dicyclohexylamine is added. The crystalline precipitate is recrystallized from isopropanol to give 1-(3-acetylthio-2-D-methylpropanoyl)-L-proline-dicyclohexylamine salt, m.p. 187-188°,

25 o 25 o

[a]Q -67 (c 1,4, EtOH). Dette salt omdannes til den frie syren, sm.p. 83-85° (en isomorf form med sm.p. 104-105° oppnås [α]Q -67 (c 1.4, EtOH). This salt is converted into the free acid, m.p. 83-85° (an isomorphic form with m.p. 104-105° is obtained

dersom den krystalliserende løsningen tilsettes høytsmeltende materiale som kim). if high-melting material such as germ is added to the crystallizing solution).

Eksempel 36 Example 36

1-( 3- merkaptopropanoyl)- L- prolin- t- butylester 1-(3-mercaptopropanoyl)-L-proline-t-butyl ester

Til en omrørt løsning av 1,71 g (10 mmol) prolin-t-butylester og 1,35 g (10 mmol) 1-hydroksybenzotriazol-hydrat i 20 ml N,N'-dimetylformamid ved 0-5°, tilsettes 2,06 g (10 mmol) N,N'-dicykloheksylkarbodiimid. Blandingen omrøres i 10 minutter, fulgt av tilsetning av 1,06 g (10 mmol) 3-merkaptopropansyre i 2 ml N,N'-dimetylformamid. Blandingen omrøres så ved 0-5° i en time og ved romtemperatur over natten. To a stirred solution of 1.71 g (10 mmol) proline-t-butyl ester and 1.35 g (10 mmol) 1-hydroxybenzotriazole hydrate in 20 ml N,N'-dimethylformamide at 0-5°, is added 2, 06 g (10 mmol) N,N'-dicyclohexylcarbodiimide. The mixture is stirred for 10 minutes, followed by the addition of 1.06 g (10 mmol) of 3-mercaptopropanoic acid in 2 ml of N,N'-dimethylformamide. The mixture is then stirred at 0-5° for one hour and at room temperature overnight.

Det utfelte N,N'-dicykloheksylurea avfiltreres og filtratet konsentreres i vakuum. Residuet opptas i etylacetat, vaskes grundig med mettet, vandig natriumbikarbonat, tørres og konsentreres i vakuum til 2,5 g olje. The precipitated N,N'-dicyclohexylurea is filtered off and the filtrate is concentrated in vacuo. The residue is taken up in ethyl acetate, washed thoroughly with saturated aqueous sodium bicarbonate, dried and concentrated in vacuo to 2.5 g of oil.

Oljen opptas i 1:1 etylacetat-heksan og påføres på en silikagelkolonne (100 g). Eluering med 1:1 etylacetat-heksan gir 1,40 g (54%) 1-(3-merkaptopropanoyl)-L-prolin-t-butylester som en olje som krystalliserer ved henstand. Omkrystallisasjon fra eter-heksan gir 0,9 g farveløst, krystallinsk fast stoff, sm.p. 55-60°, identisk med forbindelsen fra eksempel 8. The oil is taken up in 1:1 ethyl acetate-hexane and applied to a silica gel column (100 g). Elution with 1:1 ethyl acetate-hexane gives 1.40 g (54%) of 1-(3-mercaptopropanoyl)-L-proline-t-butyl ester as an oil which crystallizes on standing. Recrystallization from ether-hexane gives 0.9 g of colorless, crystalline solid, m.p. 55-60°, identical to the compound from example 8.

E ksempel 37 Example 37

1-( 3- merkaptopropanoyl)- L- prolin 1-(3-mercaptopropanoyl)-L-proline

En løsning av 75 mg (0,27 mmol) 1-[3-[[(etylamino)-karbonyl]tio]propanoyl]-L-prolin i 1 ml av hver av konsentrert ammoniumhydroksyd og vann får stå ved romtemperatur i 18 timer under argon. Løsningen fortynnes med en liten mengde vann og ekstraheres med eter. Det vandige skiktet surgjøres med kald, konsentrert saltsyre og ekstraheres med etylacetat. De kombinerte ekstrakter tørres og konsentreres i vakuum og gir en forbindelse som er identisk med produktet fra eksempel 9. TLC (silikagel, benzen:eddiksyre 7:3) Rf = 0,4. A solution of 75 mg (0.27 mmol) of 1-[3-[[(ethylamino)-carbonyl]thio]propanoyl]-L-proline in 1 ml each of concentrated ammonium hydroxide and water is allowed to stand at room temperature for 18 hours under argon. The solution is diluted with a small amount of water and extracted with ether. The aqueous layer is acidified with cold, concentrated hydrochloric acid and extracted with ethyl acetate. The combined extracts are dried and concentrated in vacuo to give a compound identical to the product from Example 9. TLC (silica gel, benzene:acetic acid 7:3) Rf = 0.4.

Eksempel 38 Example 38

1-( 3- acetyltio- 2- D- metylpropanoy1)- L- prolin 1-(3-Acetylthio-2-D-methylpropanoyl)-L-proline

L-prolin (23,0 g, 0,2 mol) oppløses i 100 ml vann og om-røres i et isbad. Metakryloylklorid (19,6 ml, 0,2 mol) i 25 ml metylisobutylketon tilsettes dråpevis i løpet av tre timer. Natriumhydroksydløsning (2N) tilsettes samtidig, hvorved pH i reaksjonsblandingen holdes på 7,0. Tilsetning av base fortsettes i fire timer efter at tilsetningen av syrekloridet er ferdig. Reaksjonsblandingen justeres til pH 5 med konsentrert HC1 og ekstraheres med etylacetat. Det vandige skiktet surgjøres så til pH 2,5 og ekstraheres grundig med etylacetat. De sure ekstraktene vaskes med saltløsning og tørres (MgS04)„ Etylacetatløsningen behandles med dicykloheksylamin (40 ml) og avkjøles over råtten. Det resulterende hvite bunnfall avfUtreres og tørres, og det oppnås 29 g (39%) av et hvitt fast stoff, sm.p. 202-210°. L-proline (23.0 g, 0.2 mol) is dissolved in 100 ml of water and stirred in an ice bath. Methacryloyl chloride (19.6 ml, 0.2 mol) in 25 ml of methyl isobutyl ketone is added dropwise over three hours. Sodium hydroxide solution (2N) is added at the same time, whereby the pH of the reaction mixture is kept at 7.0. Addition of base is continued for four hours after the addition of the acid chloride has been completed. The reaction mixture is adjusted to pH 5 with concentrated HCl and extracted with ethyl acetate. The aqueous layer is then acidified to pH 2.5 and extracted thoroughly with ethyl acetate. The acidic extracts are washed with saline and dried (MgSO 4 )„ The ethyl acetate solution is treated with dicyclohexylamine (40 ml) and cooled over the rot. The resulting white precipitate is filtered off and dried to give 29 g (39%) of a white solid, m.p. 202-210°.

Det faste stoff krystalliseres fra 1,5 liter 3:1 acetonitril/ isopropanol for å gi 19,7 g metakryloyl-L-prolin-dicykloheksylaminsalt som fine hvite nåler, sm.p. 202-210°. The solid is crystallized from 1.5 liters of 3:1 acetonitrile/isopropanol to give 19.7 g of methacryloyl-L-proline-dicyclohexylamine salt as fine white needles, m.p. 202-210°.

Saltet oppløses i vann/etylacetat og blandingen surgjøres med konsentrert HC1. Den resulterende suspensjon filtreres for å fjerne et hvitt, fint bunnfall som vaskes godt med etylacetat. Filtratet mettes med natriumklorid og ekstraheres grundig med etylacetat. Ekstraktene vaskes med saltløsning, tørres (MgSO^) The salt is dissolved in water/ethyl acetate and the mixture is acidified with concentrated HCl. The resulting suspension is filtered to remove a white fine precipitate which is washed well with ethyl acetate. The filtrate is saturated with sodium chloride and extracted thoroughly with ethyl acetate. The extracts are washed with salt solution, dried (MgSO^

og inndampes til en klår olje som blir fast. Krystallisasjon fra etylacetat/heksan gir 7,5 g (83%) metakryloyl-L-prolin som et hvitt, krystallinsk fast stoff, sm.p0 89-93°. En analytisk prøve oppnås ved omkrystallisasjon, sm.p. 95-98°. and evaporated to a clear oil which becomes solid. Crystallization from ethyl acetate/hexane gives 7.5 g (83%) of methacryloyl-L-proline as a white, crystalline solid, mp 89-93°. An analytical sample is obtained by recrystallization, m.p. 95-98°.

Metakryloyl-L-prolin (183 mg, 0,001 mol) oppløses i tioleddiksyre (0,5 ml) og får stå ved romtemperatur i 16 timer. Løsningen inndampes i vakuum til en gul rest. Preparativ tynnskiktskromatografi (silikagel, diklormetan/metanol/eddiksyre 90:5:5) muliggjør isolasjon av en klar olje (240 mg) som hoved-fraksjon. TLC (diklormetan/metanol/eddiksyre 90:5:5) viser at dette materiale er 1-(3-acetyltio-2-DL-metylpropanoyl)-L-prolin tilsvarende produktet fra eksempel 15B. Rf = 0,35; (benzen/eddiksyre 75:2 5) Rf = 0,38. Methacryloyl-L-proline (183 mg, 0.001 mol) is dissolved in thiolacetic acid (0.5 ml) and allowed to stand at room temperature for 16 hours. The solution is evaporated in vacuo to a yellow residue. Preparative thin-layer chromatography (silica gel, dichloromethane/methanol/acetic acid 90:5:5) enables the isolation of a clear oil (240 mg) as the main fraction. TLC (dichloromethane/methanol/acetic acid 90:5:5) shows that this material is 1-(3-acetylthio-2-DL-methylpropanoyl)-L-proline corresponding to the product from example 15B. R f = 0.35; (benzene/acetic acid 75:2 5) Rf = 0.38.

Oljen oppløses i 3 ml acetonitril, behandles med dicykloheksylamin inntil løsningen er basisk, og avkjøles» Et hvitt, krystallinsk fast stoff, sm.p. 175-181° (106 mg) oppsamles. Krystallisasjon fra isopropanol gir 1-(3-acetyltio-2-D-metylpropanoyl)-L-prolin-dicykloheksylaminsalt, sm.p. 187-188°,• identisk med tilsvarende produkt i eksempel 15A. The oil is dissolved in 3 ml of acetonitrile, treated with dicyclohexylamine until the solution is basic, and cooled» A white, crystalline solid, m.p. 175-181° (106 mg) is collected. Crystallization from isopropanol gives 1-(3-acetylthio-2-D-methylpropanoyl)-L-proline-dicyclohexylamine salt, m.p. 187-188°,• identical to the corresponding product in example 15A.

Eksempel 39 Example 39

1-( 3- merkapto- 2- metylpropanoyl)- L- prolin 1-(3-mercapto-2-methylpropanoyl)-L-proline

Ved å anvende 3,3<1->ditiobis-2-metylpropansyre istedenfor 3-acetyltio-2-metylpropansyre i fremgangsmåten fra eksempel 15B oppnås 1-[ditiobis-(2-metyl-3-propanoyl)]-bis-L-prolin. By using 3,3<1->dithiobis-2-methylpropanoic acid instead of 3-acetylthio-2-methylpropanoic acid in the method from example 15B, 1-[dithiobis-(2-methyl-3-propanoyl)]-bis-L-proline is obtained .

Sinkstøv (10,0 g) tilsettes til en oppslemming av ovennevnte produkt (5,0 g) i 100 ml IN svovelsyre, og blandingen omrøres ved 18° i fire timer under et nitrogenteppe. Løsningen filtreres så, sinken vaskes med vann (20 ml) og de kombinerte filtrater ekstraheres med metylenklorid (3 x 75 ml). Metylenkloridvaskeløsningene ekstraheres tilbake med vann (25 ml) og den organiske løsningen konsentreres så til en olje. Denne olje opptas i etylacetat (20 ml) og filtreres. Heksan (15 ml) tilsettes til filtratet og blandingen omrøres i 15 minutter. Efter denne tid tilsettes ytterligere heksan (30 ml) og løsningen avkjøles til 5° i 1 time. Blandingen filtreres så, og produktet vaskes med heksan (2 x 10 ml) og tørres til 4,17 g hvite krystaller av produktet, 1-(3-merkapto-2-metylpropanoyl)-L-prolin. TLC, Rf = 0,60 (Løsningsmiddelsystem: benzen/eddiksyre 75:25). Zinc dust (10.0 g) is added to a slurry of the above product (5.0 g) in 100 ml 1N sulfuric acid, and the mixture is stirred at 18° for four hours under a nitrogen blanket. The solution is then filtered, the zinc is washed with water (20 ml) and the combined filtrates are extracted with methylene chloride (3 x 75 ml). The methylene chloride washes are back-extracted with water (25 ml) and the organic solution is then concentrated to an oil. This oil is taken up in ethyl acetate (20 ml) and filtered. Hexane (15 ml) is added to the filtrate and the mixture is stirred for 15 minutes. After this time, additional hexane (30 ml) is added and the solution is cooled to 5° for 1 hour. The mixture is then filtered and the product is washed with hexane (2 x 10 mL) and dried to give 4.17 g of white crystals of the product, 1-(3-mercapto-2-methylpropanoyl)-L-proline. TLC, Rf = 0.60 (Solvent system: benzene/acetic acid 75:25).

Eksempel 40 Example 40

1-[ 3-( benzyltio)- 2- metylpropanoyl]- L- prolin 1-[3-(benzylthio)-2-methylpropanoyl]-L-proline

Ved å anvende 3-benzyltio-2-metylpropansyre istedenfor 3-[(4-metoksyfenyl)metyltio]-2-metylpropansyre i fremgangsmåten fra eksempel 33 oppnås 1-[3-(benzyltio)-2-metylpropanoyl]-L-prolin-tert-butylester. By using 3-benzylthio-2-methylpropanoic acid instead of 3-[(4-methoxyphenyl)methylthio]-2-methylpropanoic acid in the method from example 33, 1-[3-(benzylthio)-2-methylpropanoyl]-L-proline tert is obtained -butyl ester.

1-[3-(benzyltio)-2-metylpropanoy1]-L-prolin-tert-butylester (7,8 g) oppløses i en blanding av anisol (55 ml) og trifluoreddiksyre (110 ml). Efter 1 times lagring ved romtemperatur fjernes løsningsmidlet i vakuum og residuet oppløses i eter, vaskes flere ganger med mettet natriumklorid, tørres over magnesiumsulfat og inndampes til tørrhet i vakuum for å gi 1-[3-(benzyltio)-2-metylpropanoyl]-L-prolin. Rf = 0,5 (silikagel, benzen/eddiksyre 3:1), Rf = 0,5 (silikagel, metyletylketon/eddiksyre/pyridin/vann 14:1:2:1). 1-[3-(benzylthio)-2-methylpropanoyl]-L-proline tert-butyl ester (7.8 g) is dissolved in a mixture of anisole (55 ml) and trifluoroacetic acid (110 ml). After 1 hour storage at room temperature, the solvent is removed in vacuo and the residue is dissolved in ether, washed several times with saturated sodium chloride, dried over magnesium sulfate and evaporated to dryness in vacuo to give 1-[3-(benzylthio)-2-methylpropanoyl]-L -proline. Rf = 0.5 (silica gel, benzene/acetic acid 3:1), Rf = 0.5 (silica gel, methyl ethyl ketone/acetic acid/pyridine/water 14:1:2:1).

Eksempel 41 Example 41

1-( 3- merkapto- 2- metylpropanoyl)- L- prolin 1-(3-mercapto-2-methylpropanoyl)-L-proline

1-[3-(benzyltio)-2-metylpropanoyl]-L-prolin (0,1 g) suspenderes i kokende, flytende ammoniakk (10 ml) og små biter av natrium tilsettes under omrøring inntil vedvarende blåfarve. Farven fjernes med noen få ammoniumsulfatkrystaller og ammoniakken får fordampe under en nitrogenstrøm. Residuet opp-løses i en blanding av fortynnet saltsyre og etylacetat. Det organiske skiktet tørres og konsentreres til tørrhet i vakuum for å gi 1-(3-merkapto-2-metylpropanoyl)-L-prolin. Rf = 0,35 (silikagel, benzen/eddiksyre 3:1), Rf = 0,5 (silikagel, metyletylketon/eddiksyre/pyridin/vann 14:1:2:1) identisk med forbindelsen fra eksempel 17. 1-[3-(benzylthio)-2-methylpropanoyl]-L-proline (0.1 g) is suspended in boiling liquid ammonia (10 ml) and small pieces of sodium are added with stirring until a persistent blue color. The color is removed with a few ammonium sulphate crystals and the ammonia is allowed to evaporate under a stream of nitrogen. The residue is dissolved in a mixture of dilute hydrochloric acid and ethyl acetate. The organic layer is dried and concentrated to dryness in vacuo to give 1-(3-mercapto-2-methylpropanoyl)-L-proline. Rf = 0.35 (silica gel, benzene/acetic acid 3:1), Rf = 0.5 (silica gel, methyl ethyl ketone/acetic acid/pyridine/water 14:1:2:1) identical to the compound from example 17.

Eksempel 42 Example 42

1- ( 3- merkapto- 2- metylpropanoyl)- L- prolin 1-(3-mercapto-2-methylpropanoyl)-L-proline

En løsning av 3-merkapto-2-metylpropansyre (1,2 g) og tritylklorid (2,9 g) i metylenklorid (50 ml) holdes ved romtemperatur i 2 timer. Blandingen oppvarmes på dampbad i 20 minutter og inndampes så til tørrhet i vakuum og residuet opp-løses i mettet vandig natriumbikarbonat og løsningen vaskes med etylacetat. Den vandige fase surgjøres til pH 3 og ekstraheres med etylacetat. Den organiske fase tørres og konsentreres til tørrhet for å gi 3-trifenylmetyltio-2-metylpropansyre. A solution of 3-mercapto-2-methylpropanoic acid (1.2 g) and trityl chloride (2.9 g) in methylene chloride (50 ml) is kept at room temperature for 2 hours. The mixture is heated on a steam bath for 20 minutes and then evaporated to dryness in vacuo and the residue is dissolved in saturated aqueous sodium bicarbonate and the solution is washed with ethyl acetate. The aqueous phase is acidified to pH 3 and extracted with ethyl acetate. The organic phase is dried and concentrated to dryness to give 3-triphenylmethylthio-2-methylpropanoic acid.

Rf =0,8 (silikagel, benzen/eddiksyre 3:1). Rf =0.8 (silica gel, benzene/acetic acid 3:1).

Ved å anvende 3-trifenylmetyltio-2-metylpropansyre istedenfor 3-[(4-metoksyfeny1)metyltio]-2-metylpropansyre i fremgangsmåten fra eksempel 33 annet avsnitt, oppnås 1-[3-(trifenyl-metyltio)-2-metylpropanoyl]-L-prolin-tert-butyl-ester. By using 3-triphenylmethylthio-2-methylpropanoic acid instead of 3-[(4-methoxyphenyl)methylthio]-2-methylpropanoic acid in the method from example 33, second section, 1-[3-(triphenyl-methylthio)-2-methylpropanoyl]- L-proline tert-butyl ester.

3-trifenylmetyltio-2-metylpropansyre (1,8 g) og N,N'-karbonyldiimidazol (0,8 g) oppløses i tetrahydrofuran (10 ml) med omrøring ved romtemperatur. Efter 20 minutters forløp tilsettes løsningen til en.blanding av L-prolin (0,6 g) og N-metylmorfolin (1 g) i dimetylacetamid (20 ml). Den resulterende blanding omrøres over natten ved romtemperatur, konsentreres til tørrhet og residuet oppløses i en blanding av etylacetat og 10%ig vandig kaliumbisulfat. Det organiske skiktet separeres og tørres og konsentreres til tørrhet i vakuum for å gi l-[3- 3-Triphenylmethylthio-2-methylpropanoic acid (1.8 g) and N,N'-carbonyldiimidazole (0.8 g) are dissolved in tetrahydrofuran (10 ml) with stirring at room temperature. After 20 minutes, the solution is added to a mixture of L-proline (0.6 g) and N-methylmorpholine (1 g) in dimethylacetamide (20 ml). The resulting mixture is stirred overnight at room temperature, concentrated to dryness and the residue dissolved in a mixture of ethyl acetate and 10% aqueous potassium bisulfate. The organic layer is separated and dried and concentrated to dryness in vacuo to give l-[3-

(trifenylmetyltio)-2-metylpropanoyl]-L-prolin. (triphenylmethylthio)-2-methylpropanoyl]-L-proline.

Rf = 0,4 (silikagel, benzen/eddiksyre 3:1), Rf 1,0 (silikagel, metyletylketon/eddiksyre/pyridin/vann 14:1:2:1). Rf = 0.4 (silica gel, benzene/acetic acid 3:1), Rf 1.0 (silica gel, methyl ethyl ketone/acetic acid/pyridine/water 14:1:2:1).

1-[3-(trifenylmetyltio)-2-metylpropanoyl]-L-prolin-tert-butylester (5 g) oppløses i en blanding av anisol (55 ml) og trifluoreaaiksyre (110 ml). Efter 1 times oppbevaring ved romtemperatur fjernes løsningsmidlene i vakuum og residuet påføres på en silikagelkolonne som er ekvilibrert med benzen: eddiksyre (75:25) og elueres med samme løsningsmiddel. De fraksjoner som tilsvarer komponenten med Rf 0,40 (TLC silikagel. 1-[3-(Triphenylmethylthio)-2-methylpropanoyl]-L-proline tert-butyl ester (5 g) is dissolved in a mixture of anisole (55 ml) and trifluoroacetic acid (110 ml). After 1 hour of storage at room temperature, the solvents are removed in vacuo and the residue is applied to a silica gel column that is equilibrated with benzene:acetic acid (75:25) and eluted with the same solvent. The fractions corresponding to the component with Rf 0.40 (TLC silica gel.

med samme system) samles og konsentreres til tørrhet for å gi a.-[3-merkapto-2-metylpropanoyl)-L-prolin. Rf 0,62 (silikagel, fkloroform/metanol:eddiksyre:vann 50:40:10), identisk med forbindelsen fra eksempel 17. with the same system) are collected and concentrated to dryness to give α.[3-mercapto-2-methylpropanoyl)-L-proline. Rf 0.62 (silica gel, fchloroform/methanol:acetic acid:water 50:40:10), identical to the compound from example 17.

/ /

/ Eksempel 4 3 / Example 4 3

/ /

/ 1-( 3- merkapto- 2- metylpropanoyl)- L- prolin / 1-(3-mercapto-2-methylpropanoyl)-L-proline

Til en løsning av 3-merkapto-2-metyl-propansyre (2,4 g) og nydestillert 2,3-dihydro-4H-pyran (1,9 g) i benzen (60 ml) tilsettes bortrifluorideterat (2,8 g). Efter 2 timers forløp tilsettes kaliumkarbonat (4 g), blandingen omrøres og filtreres. Filtratet konsentreres til tørrhet for å gi 3-(tetrahydropyran-2-yltio)-2-metylpropansyre. To a solution of 3-mercapto-2-methyl-propanoic acid (2.4 g) and freshly distilled 2,3-dihydro-4H-pyran (1.9 g) in benzene (60 ml) is added boron trifluoride etherate (2.8 g) . After 2 hours, potassium carbonate (4 g) is added, the mixture is stirred and filtered. The filtrate is concentrated to dryness to give 3-(tetrahydropyran-2-ylthio)-2-methylpropanoic acid.

Ved å anvende 3-(tetrahydropyran-2-yltio)-2-metylpropansyre istedenfor 3-trifenylmetyltio-2-metylpropansyre ved fremgangsmåten fra eksempel 42 annet avsnitt, oppnås 1-[3-(tetrahydropyran-2-yltio)-2-metylpropanoyl]-L-prolin. Rf: 0,8 (silikagel, benzen/ eddiksyre 3:1); Rf: 0,75 (silikagel, metyletylketon/eddiksyre/ pyridin/vann 14:1:2:1). By using 3-(tetrahydropyran-2-ylthio)-2-methylpropanoic acid instead of 3-triphenylmethylthio-2-methylpropanoic acid in the method from example 42 second section, 1-[3-(tetrahydropyran-2-ylthio)-2-methylpropanoyl] is obtained -L-proline. Rf: 0.8 (silica gel, benzene/acetic acid 3:1); Rf: 0.75 (silica gel, methyl ethyl ketone/acetic acid/pyridine/water 14:1:2:1).

En løsning av 1-[3-(tetrahydropyran-2-yltio)-2-mety1-propanoyl)-L-prolin (1 g) i en blanding av metanol (25 ml) og konsentrert saltsyre (25 ml) oppbevares ved romtemperatur i 30 minutter. Løsningsmidlene fjernes i vakuum for å gi l-(3-merkapto-2-metylpropanoyl)-L-prolin. Rf: 0,35 (silikagel, benzen/eddiksyre, 3:1), Rf: 0,5 (silikagel, metyletylketon/ eddiksyre/pyridin/vann, 14:1:2:1), identisk med forbindelsen fra eksempel 17. A solution of 1-[3-(tetrahydropyran-2-ylthio)-2-methyl-propanoyl)-L-proline (1 g) in a mixture of methanol (25 ml) and concentrated hydrochloric acid (25 ml) is kept at room temperature in 30 minutes. The solvents are removed in vacuo to give 1-(3-mercapto-2-methylpropanoyl)-L-proline. Rf: 0.35 (silica gel, benzene/acetic acid, 3:1), Rf: 0.5 (silica gel, methyl ethyl ketone/acetic acid/pyridine/water, 14:1:2:1), identical to the compound from example 17.

Eksempel 44 Example 44

1-( 3- merkapto- 2- metylpropanoyl)- L- prolin 1-(3-mercapto-2-methylpropanoyl)-L-proline

3-merkapto-2-metylpropansyre (2,4 g) og N-hydroksymetyl-acetamid (1,8 g) oppløses i trifluoreddiksyre og løsningen oppbevares ved romtemperatur i 1 time. Trifluoreddiksyren fjernes i vakuum og residuet tørres i vakuum over kaliumhydroksyd slik at det oppnås 3-acetamidometyltio-2-metylpropansyre. 3-mercapto-2-methylpropanoic acid (2.4 g) and N-hydroxymethyl-acetamide (1.8 g) are dissolved in trifluoroacetic acid and the solution is kept at room temperature for 1 hour. The trifluoroacetic acid is removed in vacuo and the residue is dried in vacuo over potassium hydroxide so that 3-acetamidomethylthio-2-methylpropanoic acid is obtained.

Ved å anvende 3-acetamidometyltio-2-metylpropansyre istedenfor 3-(tetrahydropyran-2-yltio)-2-metylpropansyre i fremgangsmåten fra eksempel 43 oppnås 1-[3-(acetamidometyltio)-2-metylpropanoyl]-L-prolin. Rf 0,2 (silikagel, benzen/eddiksyre 3:1), Rf 0,3 (silikagel, metyletylketon/eddiksyre/pyridin/vann 14:1:2:1). By using 3-acetamidomethylthio-2-methylpropanoic acid instead of 3-(tetrahydropyran-2-ylthio)-2-methylpropanoic acid in the method from example 43, 1-[3-(acetamidomethylthio)-2-methylpropanoyl]-L-proline is obtained. Rf 0.2 (silica gel, benzene/acetic acid 3:1), Rf 0.3 (silica gel, methyl ethyl ketone/acetic acid/pyridine/water 14:1:2:1).

1-[3-(acetamidometyltio)-2-metylpropanoyl]-L-prolin (1,4 g) kvikksølv(II)acetat (1,93 g) oppløses i en blanding av eddiksyre (25 ml) og vann (25 ml). Efter 1 times omrøring på dampbad bobles hydrogensulfid gjennom inntil det ikke observeres mer utfelling av kvikksølv(II)sulfid. Blandingen filtreres, bunnfallet vaskes med etanol, og filtratet konsentreres til tørrhet i vakuum for å gi 1-(3-merkapto-2-metylpropanoyl)-L-prolin. 1-[3-(acetamidomethylthio)-2-methylpropanoyl]-L-proline (1.4 g) mercury (II) acetate (1.93 g) is dissolved in a mixture of acetic acid (25 ml) and water (25 ml) . After 1 hour of stirring on a steam bath, hydrogen sulphide is bubbled through until no more precipitation of mercury(II) sulphide is observed. The mixture is filtered, the precipitate is washed with ethanol, and the filtrate is concentrated to dryness in vacuo to give 1-(3-mercapto-2-methylpropanoyl)-L-proline.

Rf: 0,35 (silikagel, benzen/eddiksyre 3:1); Rf: 0,5 (silikagel, metyletylketon/eddiksyre/pyridin/vann 14:1:2:1), identisk med forbindelsen fra eksempel 17. Rf: 0.35 (silica gel, benzene/acetic acid 3:1); Rf: 0.5 (silica gel, methyl ethyl ketone/acetic acid/pyridine/water 14:1:2:1), identical to the compound from example 17.

Eksempel 4 5 Example 4 5

1- ( 3- merkapto- 2- metylpropanoyl)- L- prolin- tert- butylester 1-( 3- mercapto- 2- methylpropanoyl)- L- proline- tert-butyl ester

Til den kalde (5°) løsning av 1,2 g (10 mmol) 3-merkapto-2- metylpropansyre og 1,7 g (10 mmol) L-prolin-tert-butylester i 25 ml diklormetan tilsettes 2,26 g dicykloheksylkarbodiimid i 5 ml diklormetan i porsjoner. Efter 2 timer ved romtemperatur tilsettes 5 dråper eddiksyre, blandingen filtreres og filtratet inndampes til en oljerest. Denne rest opptas i 20 ml petroleter-etylacetat (3:1) og påføres på en 150 ml silikagelkolonne fremstilt i petroleter. De fraksjoner som elueres med petroleter-etylacetat (1:1) inneholder produktet 1-(3-merkapto-2-metylpropanoyl)-L-prolin-tert-butylester. Denne fraksjon (0,6 g) tørres over P2°5 1 vakuum 1 12 timer. Rf 0,6 (silikagel, benzen/eddiksyre 3:1), Rf: 0,8 (silikagel, metyletylketon/ To the cold (5°) solution of 1.2 g (10 mmol) of 3-mercapto-2-methylpropanoic acid and 1.7 g (10 mmol) of L-proline-tert-butyl ester in 25 ml of dichloromethane is added 2.26 g of dicyclohexylcarbodiimide in 5 ml of dichloromethane in portions. After 2 hours at room temperature, 5 drops of acetic acid are added, the mixture is filtered and the filtrate is evaporated to an oil residue. This residue is taken up in 20 ml of petroleum ether-ethyl acetate (3:1) and applied to a 150 ml silica gel column prepared in petroleum ether. The fractions eluted with petroleum ether-ethyl acetate (1:1) contain the product 1-(3-mercapto-2-methylpropanoyl)-L-proline-tert-butyl ester. This fraction (0.6 g) is dried over P2°5 1 vacuum 1 12 hours. Rf 0.6 (silica gel, benzene/acetic acid 3:1), Rf: 0.8 (silica gel, methyl ethyl ketone/

eddiksyre/pyridin/vann 14:1:2:1). acetic acid/pyridine/water 14:1:2:1).

Eksempel 46 Example 46

1-( 3- merkapto- 2- metylpropanoyl)- L- prolin 1-(3-mercapto-2-methylpropanoyl)-L-proline

Ved å anvende 1-(3-merkapto-2-metylpropanoyl)-L-prolin-tert-butylester istedenfor 1-(3-merkapto-propanoyl)-L-prolin-tert-butylester i fremgangsmåten fra eksempel 9C oppnås 1-(3-merkapto-2-metylpropanoyl)-L-prolin. Rf 0,35 (silikagel, benzen/eddiksyre 3:1), Rf 0,5 (silikagel, metyletylketon/ eddiksyre/pyridin/vann 14:1:2:1), identisk med forbindelsen fra eksempel 17. By using 1-(3-mercapto-2-methylpropanoyl)-L-proline-tert-butyl ester instead of 1-(3-mercapto-propanoyl)-L-proline-tert-butyl ester in the method from example 9C, 1-(3 -mercapto-2-methylpropanoyl)-L-proline. Rf 0.35 (silica gel, benzene/acetic acid 3:1), Rf 0.5 (silica gel, methyl ethyl ketone/acetic acid/pyridine/water 14:1:2:1), identical to the compound from example 17.

Eksempel 47 Example 47

A) 1-( 3- acetyltio- 2- L- metylpropanoyl)- L- prolin A) 1-(3-acetylthio-2-L-methylpropanoyl)-L-proline

Moderluten fra eksempel 15A ble inndampet til tørrhet, og residuet ble utgnidd med acetonitril, og det resulterende krystallinske dicykloheksylaminsalt ble filtrert og tørret, sm.p. 136-138°C. Det krystallinske dicykloheksylaminsalt ble omdannet til den frie syre ifølge eksempel 15A og omkrystal-lisert fra 1:1 etylacetat-heksan som et krystallinsk, fast stoff med smeltepunkt 96-97°C. The mother liquor from Example 15A was evaporated to dryness and the residue was triturated with acetonitrile and the resulting crystalline dicyclohexylamine salt was filtered and dried, m.p. 136-138°C. The crystalline dicyclohexylamine salt was converted to the free acid according to Example 15A and recrystallized from 1:1 ethyl acetate-hexane as a crystalline solid with a melting point of 96-97°C.

B) 1-( 3- merkapto- 2L- metylpropanoyl)- L- prolin B) 1-(3-mercapto-2L-methylpropanoyl)-L-proline

Under anvendelse av produktet fra del A ved fremgangsmåten beskrevet i eksempel 17 oppnås tittelproduktet som omkrystalliseres fra etylacetat-heksan, sm.p. 104-105°C, Using the product from part A by the method described in Example 17, the title product is obtained which is recrystallized from ethyl acetate-hexane, m.p. 104-105°C,

[a]<p5> -41,1° (c = 2,32, C^OH) . [α]<p5> -41.1° (c = 2.32, C₂OH).

Eksempel 48 Example 48

1-( 3- merkapto- 2- D- metylpropanoyl)- L- hydroksyprolin 1-( 3- mercapto- 2- D- methylpropanoyl)- L- hydroxyproline

Ved å anvende 1-(3-acetyltio-2-DL-metylpropanoyl)-L-hydroksyprolin-tert.butylesteren fra eksempel 19 og å By using the 1-(3-acetylthio-2-DL-methylpropanoyl)-L-hydroxyproline tert-butyl ester from Example 19 and to

følge fremgangsmåten ifølge eksemplene 15 og 17, oppnås tittelproduktet som et hygroskopisk materiale, [cOD <-1>14° following the procedure according to examples 15 and 17, the title product is obtained as a hygroscopic material, [cOD <-1>14°

(c = 1, metanol). (c = 1, methanol).

Eksempel 49 Example 49

1- ( 3- merkapto- 2- metylpropanoyl)- L- piperidin- 2- karboksylsyre 1-( 3- mercapto- 2- methylpropanoyl)- L- piperidine- 2- carboxylic acid

Ved å anvende fremgangsmåten ifølge eksempel 14 og By using the method according to example 14 and

å benytte L-piperidin-2-karboksylsyre-t-butylester istedenfor L-prolin-t-butylester, får man 1-(3-acetyltio-2-metylpropanoyl)-L-piperidin-karboksylsyre som fraskilles ved fremgangsmåten ifølge eksempel 15 og videre som i eksempel 17 for å danne 2- D-mety li someren, sm.p. 85-90°C; CoOq5 -88° (c = 1, etanol) og 2-L-metyl-isomeren som et viskøst stoff [ci]^ -33° (c=l, etanol). using L-piperidine-2-carboxylic acid t-butyl ester instead of L-proline-t-butyl ester, 1-(3-acetylthio-2-methylpropanoyl)-L-piperidine carboxylic acid is obtained which is separated by the method according to example 15 and further as in Example 17 to form the 2-D-methyl isomer, m.p. 85-90°C; CoOq5 -88° (c = 1, ethanol) and the 2-L-methyl isomer as a viscous substance [ci]^ -33° (c=1, ethanol).

Isomer-adskillelse ble foretatt på det racemiske 1-(3-acetyltio-2-D,L-metylpropanoyl)-L-piperidin-2-karboksylsyre-trinn ved å danne dicykloheksylaminsaltet i acetonitril, Isomer separation was performed on the racemic 1-(3-acetylthio-2-D,L-methylpropanoyl)-L-piperidine-2-carboxylic acid step by forming the dicyclohexylamine salt in acetonitrile,

hvorved 2-D-metyl-isomeren ble utfelt, sm.p. 163-165°C som dicykloheksylaminsaltet; og 2-L-metylisomeren ble utvunnet fra acetonitril-filtratet som en viskøs rest. whereby the 2-D-methyl isomer was precipitated, m.p. 163-165°C as the dicyclohexylamine salt; and the 2-L-methyl isomer was recovered from the acetonitrile filtrate as a viscous residue.

Begge isomerer ble derefter omdannet tilbake til Both isomers were then converted back to

syren og hydrolysert for å gi D- og L-isomeren definert ovenfor. the acid and hydrolyzed to give the D and L isomers defined above.

Ved å anvende de tidligere beskrevne fremgangsmåter By using the previously described methods

ble de følgende forbindelser fremstilt: the following compounds were prepared:

a. 1-(3-merkapto-2-D-metylpropanoyl)-L-prolin-adamantyl-aminsalt, sm.p. 219-221°C (sintrer, 227°C). [a]^<5> -53° a. 1-(3-mercapto-2-D-methylpropanoyl)-L-proline-adamantyl-amine salt, m.p. 219-221°C (sinters, 227°C). [a]^<5> -53°

(c = 1; C2H5OH). (c = 1; C2H5OH).

b. 1-(3-merkapto-2-L-etylpropanoyl)-L-prolin, b. 1-(3-mercapto-2-L-ethylpropanoyl)-L-proline,

sm.p. 120-122°C, [a]^<0> -66,8° (c = 0,6, C^OH) . sm.p. 120-122°C, [α]^<0> -66.8° (c = 0.6, C^OH).

c. 1-(3-merkapto-2-D-etylpropanoyl)-L-prolin, c. 1-(3-mercapto-2-D-ethylpropanoyl)-L-proline,

sm.p. 100-102°C, [a]p° -79,6° (c = 0,5, C^OH) . sm.p. 100-102°C, [α]p° -79.6° (c = 0.5, C₂OH).

d. 1-(3-merkapto-2-DL-propylpropanoyl)-L-prolin, olje, [a]^° -63,1° (c = 0,44, CH30H). e. 1-(3-merkapto-2-D-metylpropanoyl)-4-metyl-L-prolin, olje, [a]" -139,7° (c = 1,26, Ct^OH) , f. 1-(3-merkapto-2-D-metylpropanoyl)-4-heptyl-L-prolin, farveløs olje, [a]p<5> -74° (c = 1, C^OH) . g. 1-(3-merkapto-2-DL-metylpropanoyl)-trans-4-hydroksy-L-prolin, sterkt hygroskopisk materiale, -73,5° (c = 0,98, CH30H). h. 1-(3-merkapto-2-D-metylpropanoyl)-trans-4-hydroksy-L-prolin, halvfast stoff. Dicykloheksylaminsaltet smelter ved 183-185°C, [a]<25> -119,2° (c = 2, CH3OH). i. 1-(3-merkapto-2-DL-metylpropanoyl)-trans-5-hydroksy-2-piperidinkarboksylsyre, halvfast, meget hygroskopisk stoff, [a]<25> -44,0° (c = 1, CH30H). d. 1-(3-mercapto-2-DL-propylpropanoyl)-L-proline, oil, [α]^° -63.1° (c = 0.44, CH 3 OH). e. 1-(3-mercapto-2-D-methylpropanoyl)-4-methyl-L-proline, oil, [a]" -139.7° (c = 1.26, Ct^OH) , f. 1 -(3-mercapto-2-D-methylpropanoyl)-4-heptyl-L-proline, colorless oil, [a]p<5> -74° (c = 1, C^OH) . g. 1-(3 -mercapto-2-DL-methylpropanoyl)-trans-4-hydroxy-L-proline, highly hygroscopic material, -73.5° (c = 0.98, CH3OH). h. 1-(3-mercapto-2- D-methylpropanoyl)-trans-4-hydroxy-L-proline, semisolid. The dicyclohexylamine salt melts at 183-185°C, [a]<25> -119.2° (c = 2, CH3OH). i. 1- (3-Mercapto-2-DL-methylpropanoyl)-trans-5-hydroxy-2-piperidinecarboxylic acid, semisolid, very hygroscopic substance, [α]<25> -44.0° (c = 1, CH3OH).

j. 1-(3-merkaptopropanoyl)-5-butyl-2-piperidin-karboksylsyre, olje, R- = 0,4 (toluen/eddiksyre 9:1). j. 1-(3-Mercaptopropanoyl)-5-butyl-2-piperidinecarboxylic acid, oil, R- = 0.4 (toluene/acetic acid 9:1).

k. 1-(3-merkapto-2-D-metylpropanoyl)-L-prolin-n-propyl-ester, flytende, k.p. 148-150°C/10~<4> Torr, [a]^<5> -117,7° k. 1-(3-mercapto-2-D-methylpropanoyl)-L-proline-n-propyl ester, liquid, b.p. 148-150°C/10~<4> Dry, [a]^<5> -117.7°

(c = 11,8, C-H..0H) . (c = 11.8, C-H..OH).

1. 1-(3-merkapto-2-D-métylpropanoyl)-L-prolin-isopropy lester, væske, [a] -131,1° (c = 14,3; C2Hj-0H) . m. 1-(3-merkapto-2-D-metylpropanoyl)-L-prolin-cyklopropyl-metylester, væske, [a]^2 -184,9° (c = 15,85, C^OH) . 1. 1-(3-mercapto-2-D-methylpropanoyl)-L-proline-isopropyl ester, liquid, [α] -131.1° (c = 14.3; C2Hj-OH) . m. 1-(3-mercapto-2-D-methylpropanoyl)-L-proline cyclopropyl methyl ester, liquid, [α]^2 -184.9° (c = 15.85, C^OH).

h. 1-(3-merkapto-2-D-metylpropanoyl)-L-prolin-n-heptyl-ester, væske, k.p. 167-169°C/0,05 Torr, [a]^<2> -108,7° h. 1-(3-mercapto-2-D-methylpropanoyl)-L-proline-n-heptyl ester, liquid, b.p. 167-169°C/0.05 Torr, [a]^<2> -108.7°

(c = 22,65, C2H5OH). (c = 22.65, C2H5OH).

o. 1-(3-merkapto-2-D-metylpropanoyl)-L-prolin-n-butylester, væske, k.p. 143-145°C/10~<4> Torr, -118,1° o. 1-(3-mercapto-2-D-methylpropanoyl)-L-proline-n-butyl ester, liquid, b.p. 143-145°C/10~<4> Dry, -118.1°

(c = 12,8, C2H5OH). (c = 12.8, C2H5OH).

p. 1-(3-merkapto-2-D-metylpropanoyl)-L-prolin-metylester, væske, k.p. 116-118°C/10<-4> Torr, [a]^<5> -132,5° (c = 1,67, C2H5OH) . p. 1-(3-mercapto-2-D-methylpropanoyl)-L-proline methyl ester, liquid, b.p. 116-118°C/10<-4> Dry, [α]^<5> -132.5° (c = 1.67, C2H5OH).

q. 1-(3-merkapto-2-DL-n-heptylpropanoyl)-L-prolin; olje. Adamantylaminsaltet smelter ved 159-162°C. q. 1-(3-mercapto-2-DL-n-heptylpropanoyl)-L-proline; oil. The adamantylamine salt melts at 159-162°C.

r. 1-(3-merkapto-2-DL-fenylheptylpropanoyl)-L-prolin, olje. Adamantylaminsaltet smelter ved 104-110°C r. 1-(3-mercapto-2-DL-phenylheptylpropanoyl)-L-proline, oil. The adamantylamine salt melts at 104-110°C

s. 1-(3-merkapto-3-DL-n-heptylpropanoyl)-L-prolin, olje. Adamantylaminsaltet smelter ved 131-133°C (med sintring). pp. 1-(3-mercapto-3-DL-n-heptylpropanoyl)-L-proline, oil. The adamantylamine salt melts at 131-133°C (with sintering).

t. 1-(3-merkapto-propanoyl)-3-heptyl-2-azetidin-karboksylsyre som et hygroskopisk fast stoff. Adamantylaminsaltet smelter ved 164-167°C. t. 1-(3-mercapto-propanoyl)-3-heptyl-2-azetidine carboxylic acid as a hygroscopic solid. The adamantyl amine salt melts at 164-167°C.

Claims (4)

1. Analogifremgangsmåte for fremstilling av en terapeutisk aktiv forbindelse med formelen hvor R er hydroksy eller C^-C^ alkoksy; R^ og R4 er hydrogen, C^-C-y alkyl, fenyl eller fenyl- (C^-C^) - alkyl; R2 er hydrogen, C^- C^ alkanoyl eller benzoyl; R^ er hydrogen, hydroksy eller C-^-c^ alkyl; m er 1, 2 eller 3; og n er 0, 1 eller 2, karakterisert ved at A) en forbindelse med formelen omsettes med en forbindelse med formelen hvor X er klor, brom eller jod, fulgt av omsetning med anionet av en tiosyre med formelen fulgt av omsetning med anionet av en tiosyre med formelen (d) et tiolakton med formelen for å danne et produkt hvor R~ er hydrogen, eller (e) en tosyloksyalkansyre med formelen fulgt av omsetning med anionet av en tiosyre med formelen eller B) den svovelbeskyttende gruppe Y fjernes i henhold til konvensjonelle metoder fra en forbindelse med formelen hvor Y er en konvensjonell svovelbeskyttende gruppe så som C^-C^ alkanoyl, f eny 1-(C-^-C^)-alkanoyl, benzoyl, benzyl, metoksybenzyl, trifenylmetyl, tetrahydropyranyl eller acetamido-metyl, for å danne en forbindelse hvor R^ er hydrogen.1. Analogous method for the preparation of a therapeutically active compound of the formula where R is hydroxy or C₁-C₁ alkoxy; R 1 and R 4 are hydrogen, C 1 -C 4 alkyl, phenyl or phenyl-(C 1 -C 4 )-alkyl; R 2 is hydrogen, C 1 -C 4 alkanoyl or benzoyl; R 1 is hydrogen, hydroxy or C 1 -C 6 alkyl; m is 1, 2 or 3; and n is 0, 1 or 2, characterized in that A) a compound with the formula is reacted with a compound with the formula where X is chlorine, bromine or iodine, followed by reaction with the anion of a thioacid of the formula followed by reaction with the anion of a thioacid of the formula (d) a thiolactone of the formula to form a product where R~ is hydrogen, or (e) a tosyloxyalkanoic acid of the formula followed by reaction with the anion of a thioacid of the formula or B) the sulfur protecting group Y is removed according to conventional methods from a compound with the formula wherein Y is a conventional sulfur-protecting group such as C 1 -C 4 alkanoyl, phenyl 1-(C 2 -C 4 )-alkanoyl, benzoyl, benzyl, methoxybenzyl, triphenylmethyl, tetrahydropyranyl or acetamido-methyl, to form a compound where R 1 is hydrogen. 2. Fremgangsmåte som angitt i krav 1 for fremstilling av 1-(3-merkapto-2-D-metylpropanoyl)-L-prolin, karakterisert ved at det anvendes utgangs- . materialer hvor R er OH, R^ er metyl, R2, R^ og R4 er hydrogen, m er 2 og n er 1, eller R, R2 og/eller R^ omdannes dertil.2. Process as stated in claim 1 for the production of 1-(3-mercapto-2-D-methylpropanoyl)-L-proline, characterized in that starting materials where R is OH, R^ is methyl, R2, R^ and R4 are hydrogen, m is 2 and n is 1, or R, R 2 and/or R 3 are converted thereto. 3, Fremgangsmåte som angitt i krav 1 for fremstilling av 1-(3-merkapto-2-D-metylpropanoyl)-L-hydroksyprolin, karakterisert ved at det anvendes utgangs-materialer hvor R er OH, R1 er metyl, R2 og R4 er hydrogen, R^ er—OH, m er 2 og n er 1, eller R, R2 og/eller R^ omdannes dertil.3, Process as stated in claim 1 for the production of 1-(3-mercapto-2-D-methylpropanoyl)-L-hydroxyproline, characterized in that starting materials are used where R is OH, R1 is methyl, R2 and R4 are hydrogen, R₂ is —OH, m is 2 and n is 1, or R, R₂ and/or R₂ are converted thereto. 4. Fremgangsmåte som angitt i krav 1 for fremstilling av 1-(3-merkapto-2-D-metylpropanoyl)-trans-4-hydroksy-L-prolin, karakterisert ved at det anvendes utgangs-materialer hvor R er OH, R^ er metyl, R2 og R^ er hydrogen, R-j er —OH, m er 2 og n er 1, eller R, R2 og/eller R^ omdannes dertil.4. Process as stated in claim 1 for the production of 1-(3-mercapto-2-D-methylpropanoyl)-trans-4-hydroxy-L-proline, characterized in that starting materials are used where R is OH, R is methyl, R 2 and R 3 are hydrogen, R-j is —OH, m is 2 and n is 1, or R, R 2 and/or R 3 are converted thereto.
NO770464A 1976-02-13 1977-02-11 ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE PROLIN-AZETIDINE AND PIPERIDINE DERIVATIVES NO146985C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US05/657,792 US4046889A (en) 1976-02-13 1976-02-13 Azetidine-2-carboxylic acid derivatives
US69843276A 1976-06-21 1976-06-21
US05/751,851 US4105776A (en) 1976-06-21 1976-12-22 Proline derivatives and related compounds

Publications (3)

Publication Number Publication Date
NO770464L NO770464L (en) 1977-08-16
NO146985B true NO146985B (en) 1982-10-04
NO146985C NO146985C (en) 1983-01-12

Family

ID=27417986

Family Applications (1)

Application Number Title Priority Date Filing Date
NO770464A NO146985C (en) 1976-02-13 1977-02-11 ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE PROLIN-AZETIDINE AND PIPERIDINE DERIVATIVES

Country Status (31)

Country Link
JP (1) JPS604815B2 (en)
AR (4) AR222445A1 (en)
AT (1) AT365569B (en)
AU (1) AU509899B2 (en)
BG (3) BG37075A3 (en)
CA (1) CA1101864A (en)
CH (3) CH622503A5 (en)
DD (1) DD129442B3 (en)
DE (2) DE2703828C2 (en)
DK (1) DK157487C (en)
ES (5) ES455803A1 (en)
FI (1) FI66596C (en)
FR (1) FR2340932A1 (en)
GB (1) GB1576161A (en)
GR (1) GR69811B (en)
HK (1) HK20281A (en)
HU (1) HU181965B (en)
IE (1) IE44707B1 (en)
IL (1) IL51297A (en)
IT (1) IT1062293B (en)
KE (1) KE3136A (en)
MY (2) MY8200075A (en)
NL (1) NL168509C (en)
NO (1) NO146985C (en)
NZ (1) NZ183130A (en)
PH (1) PH12970A (en)
PL (1) PL118161B1 (en)
RO (1) RO69941A (en)
SE (2) SE423812B (en)
SU (1) SU747422A3 (en)
YU (1) YU40664B (en)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206122A (en) * 1978-04-14 1980-06-03 E. R. Squibb & Sons, Inc. Derivatives of pyrrolidinecarboxaldehyde and piperidinecarboxaldehyde and intermediates therefor
US4053651A (en) 1976-05-10 1977-10-11 E. R. Squibb & Sons, Inc. Compounds and method for alleviating angiotensin related hypertension
AU518147B2 (en) * 1976-12-03 1981-09-17 E.R. Squibb & Sons, Inc. Derivatives of thiazolidine, thiazine and morpholine carboxylic acids
US4129566A (en) * 1978-02-15 1978-12-12 E. R. Squibb & Sons, Inc. Derivatives of dehydrocyclicimino acids
US4113715A (en) * 1977-01-17 1978-09-12 E. R. Squibb & Sons, Inc. Amino acid derivatives
FR2412537A1 (en) * 1977-12-22 1979-07-20 Science Union & Cie NEW SUBSTITUTE THIOBUTYRAMIDES, THEIR METHODS OF OBTAINING AND THEIR PHARMACEUTICAL APPLICATION
CA1120400A (en) * 1977-12-27 1982-03-23 Zola P. Horovitz Method of treating hypertension and medicaments therefor
PH15381A (en) * 1978-02-21 1982-12-17 Squibb & Sons Inc Halogen substituted mercaptoacylamino acids
JPS559058A (en) * 1978-07-06 1980-01-22 Dainippon Pharmaceut Co Ltd 1-(3-mercapto-2-methylpropanoyl)prolyl amino acid derivative
CA1109475A (en) * 1978-07-27 1981-09-22 Miguel A. Ondetti Thiopropanoylamino acid derivatives
CA1144930A (en) * 1978-08-11 1983-04-19 Miguel A. Ondetti Mercaptoacyl derivatives of substituted prolines
NZ190995A (en) * 1978-09-05 1982-03-09 American Cyanamid Co Substituted omega propionyl or butyryl l-prolines and pharmaceutical compositions
NL7809120A (en) * 1978-09-07 1980-03-11 Oce Andeno B V Grubbenvorsterw PROCESS FOR THE PREPARATION OF PROLINE DERIVATIVES.
NL7809121A (en) * 1978-09-07 1980-03-11 Oce Andeno B V Grubbenvorsterw OPTICALLY ACTIVE DERIVATIVES OF MERCAPTO-ISO BUTIC ACID.
ZA794723B (en) * 1978-09-11 1980-08-27 Univ Miami Anti-hypertensive agents
US4690937A (en) * 1979-08-14 1987-09-01 University Of Miami Anti-hypertensive agents
GR73585B (en) * 1978-09-11 1984-03-26 Univ Miami
JPS5540622A (en) * 1978-09-14 1980-03-22 Santen Pharmaceut Co Ltd Hypotensive agent
US4483861A (en) * 1978-10-31 1984-11-20 Santen Pharmaceutical Co., Ltd. Antihypertensive sulfur-containing compounds
US4198515A (en) * 1978-12-08 1980-04-15 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of 4,5-dihydro-1H-pyrrole-2-carboxylic acids and 1,4,5,6-tetrahydropyridine-2-carboxylic acids
US4347371A (en) * 1978-12-30 1982-08-31 Santen Pharmaceutical Co., Ltd. Disulfide compounds
US4410542A (en) 1978-12-30 1983-10-18 Santen Pharmaceutical Co., Ltd. Disulfide compounds
CA1138452A (en) * 1979-01-15 1982-12-28 John Krapcho Carbamate derivatives of mercaptoacyl hydroxy prolines
US4461896A (en) * 1979-02-07 1984-07-24 Norwich Eaton Pharmaceuticals, Inc. 1-[Acylthio) and (mercapto)-1-oxoalkyl]-1,2,3,4-tetrahydroquinoline-2-carboxylic acids
US4220791A (en) * 1979-03-08 1980-09-02 E. R. Squibb & Sons, Inc. Mercaptoacylpyrazolidinone carboxylic acid derivatives
ZA802420B (en) * 1979-05-18 1981-04-29 Squibb & Sons Inc Aminoacyl derivatives of mercaptoacyl amino acids
US4234489A (en) * 1979-06-25 1980-11-18 E. R. Squibb & Sons, Inc. Pyroglutamic acid derivatives and analogs
JPS5629403U (en) * 1979-08-13 1981-03-20
DE2937779A1 (en) * 1979-09-19 1981-04-09 Hoechst Ag, 6000 Frankfurt AMINO ACID DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
GB2066240A (en) * 1979-12-10 1981-07-08 Squibb & Sons Inc Derivatives of mercaptoacyl amino acids
GB2065643B (en) * 1979-12-13 1983-08-24 Kanegafuchi Chemical Ind Optically active n-mercaptoalkanoylamino acids
JPS5683483A (en) * 1979-12-13 1981-07-08 Santen Pharmaceut Co Ltd Thiazolidine compound
US4692458A (en) * 1980-03-05 1987-09-08 University Of Miami Anti-hypertensive agents
GB2070586A (en) * 1980-03-21 1981-09-09 Squibb & Sons Inc Derivatives of Proline or Pipecolic Acid
DE3011239A1 (en) * 1980-03-22 1981-10-01 C.H. Boehringer Sohn, 6507 Ingelheim SUBSTITUTED ALKYLTHIOACYLAMINO ACIDS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS
SE8203245L (en) * 1981-05-27 1982-11-28 Crc Ricerca Chim PROCEDURE FOR ENANTIOSELECTIVE PREPARATION OF N-SUBSTITUTED PROLINE DERIVATIVES
KR860001391B1 (en) * 1984-07-23 1986-09-22 보령제약 주식회사 Process for the preparation of pyrolidines
JPH06740B2 (en) * 1984-08-16 1994-01-05 三菱レイヨン株式会社 Process for producing optically active carboxylic acid amide
HU196369B (en) * 1984-10-18 1988-11-28 Egyt Gyogyszervegyeszeti Gyar New process for producing n-acylized l-prolin derivatives
KR870001570B1 (en) * 1984-12-19 1987-09-04 보령제약 주식회사 Preparing process for pyrolidine derivatives
KR870001569B1 (en) * 1985-02-11 1987-09-04 보령제약 주식회사 Preparing process for pyrolidine derivatives
AT395012B (en) * 1986-06-27 1992-08-25 Richter Gedeon Vegyeszet METHOD FOR PRODUCING N- (1 (S) | THOXYCARBONYL-3-PHENYL-PROPYL) - (S) -ALANYL- (S) PROLIN AND ITS ACID ADDITION SALTS
JP2863534B2 (en) * 1988-10-24 1999-03-03 マリオン ラボラトリーズ,インコーポレイティド Pharmaceutical composition
US5026873A (en) * 1989-11-06 1991-06-25 E. R. Squibb & Sons, Inc. Process for direct isolation of captopril
EP0656773B1 (en) * 1992-08-26 1997-04-02 Beiersdorf Aktiengesellschaft Use of radical catchers as immunomodulating agents in cosmetic and dermatological compositions
DE4228455A1 (en) * 1992-08-26 1994-09-15 Beiersdorf Ag Cosmetic and dermatological sunscreen formulations containing thiols and / or thiol derivatives
IT1266570B1 (en) * 1993-07-30 1997-01-09 Zambon Spa DERIVATIVES OF PROPANAMIDE N-ETEROARYL SUBSTITUTES USEFUL IN THE TREATMENT OF CARDIOVASCULAR DISEASES
US7056935B2 (en) 1995-06-07 2006-06-06 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
GB9704522D0 (en) * 1997-03-05 1997-04-23 Smithkline Beecham Plc Compounds
ES2182203T3 (en) 1997-10-31 2003-03-01 Hoffmann La Roche DERIVATIVES OF D-PROLINA.
CA2457814A1 (en) * 2001-08-07 2003-02-20 Sunesis Pharmaceuticals, Inc. Disulfide and thiosulfonate ligands and libraries comprising these ligands
CN100361971C (en) * 2005-09-19 2008-01-16 华中师范大学 Double functional group L-proline derivative with adjustable catalytic activity and its prepn
US8653131B2 (en) 2008-08-22 2014-02-18 Baxter Healthcare S.A. Polymeric benzyl carbonate-derivatives
CN104822266B (en) 2012-04-27 2017-12-05 陶氏益农公司 Pesticidal combination and relative method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA946836A (en) * 1970-03-18 1974-05-07 Miguel A. Ondetti Enzyme inhibitor

Also Published As

Publication number Publication date
ES455803A1 (en) 1978-06-16
ES467051A1 (en) 1978-11-01
ES467050A1 (en) 1978-11-01
DK157487C (en) 1990-06-11
MY102705A (en) 1992-09-30
NZ183130A (en) 1979-08-31
AR222783A1 (en) 1981-06-30
ES467053A1 (en) 1978-11-01
GB1576161A (en) 1980-10-01
FI66596B (en) 1984-07-31
CH624932A5 (en) 1981-08-31
AR226290A1 (en) 1982-06-30
RO69941A (en) 1980-05-15
FI770437A (en) 1977-08-14
ATA98977A (en) 1981-06-15
DE2759862C2 (en) 1989-12-07
FI66596C (en) 1987-03-18
DE2703828C2 (en) 1984-06-20
SE7701561L (en) 1977-09-23
SU747422A3 (en) 1980-07-23
NO146985C (en) 1983-01-12
BG37375A3 (en) 1985-05-15
NL7701457A (en) 1977-08-16
AU2134777A (en) 1978-07-20
SE8104660L (en) 1981-08-03
JPS52116457A (en) 1977-09-29
YU33177A (en) 1983-01-21
DE2703828A1 (en) 1977-08-18
GR69811B (en) 1982-07-13
AR214649A1 (en) 1979-07-13
SE423812B (en) 1982-06-07
FR2340932B1 (en) 1981-02-06
SE426697B (en) 1983-02-07
JPS604815B2 (en) 1985-02-06
DD129442A5 (en) 1978-01-18
IL51297A (en) 1980-03-31
FR2340932A1 (en) 1977-09-09
AU509899B2 (en) 1980-05-29
CA1101864A (en) 1981-05-26
ES467052A1 (en) 1978-11-01
BG37074A3 (en) 1985-03-15
NL168509C (en) 1982-04-16
BG37075A3 (en) 1985-03-15
PL118161B1 (en) 1981-09-30
DD129442B3 (en) 1990-01-10
DK157487B (en) 1990-01-15
PH12970A (en) 1979-10-24
IL51297A0 (en) 1977-03-31
AT365569B (en) 1982-01-25
IE44707B1 (en) 1982-03-10
IT1062293B (en) 1984-05-23
HU181965B (en) 1983-11-28
IE44707L (en) 1977-08-13
DK59677A (en) 1977-08-14
HK20281A (en) 1981-05-22
MY8200075A (en) 1982-12-31
PL195965A1 (en) 1978-02-27
AR222445A1 (en) 1981-05-29
CH622503A5 (en) 1981-04-15
YU40664B (en) 1986-04-30
CH624931A5 (en) 1981-08-31
KE3136A (en) 1981-07-03
NO770464L (en) 1977-08-16

Similar Documents

Publication Publication Date Title
NO146985B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE PROLIN-AZETIDINE AND PIPERIDINE DERIVATIVES
US4154935A (en) Halogen substituted mercaptoacylamino acids
US4046889A (en) Azetidine-2-carboxylic acid derivatives
KR830002450B1 (en) Method for preparing mercaptoacyl derivative of substituted proline
US4129566A (en) Derivatives of dehydrocyclicimino acids
US4086338A (en) N-carboxyalkanoyl derivatives of azetidine-2-carboxylic acid
US4105776A (en) Proline derivatives and related compounds
NO781392L (en) MARKAPTOALKYLSYLPHONYL-PROLIN DERIVATIVES AND RELATED COMPOSITIONS
EP0022219A1 (en) 5-Oxo- and 5-Thioxoproline derivatives, process for their production and pharmaceutical compositions containing them
US4154937A (en) Hydroxycarbamoylalkylacylpipecolic acid compounds
NO148416B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE TIAZOLIDINE, MORPHOLINE AND TIAZAN DERIVATIVES
US4296033A (en) 4-Azido-1-mercaptoacyl proline
US4241076A (en) Halogenated substituted mercaptoacylamino acids
CA1124723A (en) Halogen substituted mercaptoacylamino-prolines and pipecolic acids
NO155240B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE AROYL (PROPIONYL OR BUTYRYL) -L-PROLINE DERIVATIVES.
CA1124726A (en) Derivatives of pyrrolidinecarboxaldehyde and piperidinecarboxaldehyde and intermediates therefor
US4181663A (en) Selenium containing derivatives of proline and pipecolic acid
CA1103255A (en) Proline derivatives and related compounds
US4308388A (en) 4-Azido-1-mercaptoacyl pipecolic acid
KR820001832B1 (en) Process for preparing halogen substituted mercaptoacylamino acids
SE426698B (en) New therapeutically active derivatives of 3,4- dehydroproline
PL118386B1 (en) Process for preparing novel derivatives of mercaptoacyl substituted prolines zamehhennykh prolinov
NO800620L (en) PROCEDURE FOR THE PREPARATION OF PROLINIC AND PIPE CARBIC ACID DERIVATIVES.
NO149350B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TIOPROPANOYLAMINO ACID DERIVATIVES